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On the Contribution of MMP-2 and MMP-9 to the Postnatal Cerebellar 
Corticogenesis 
 
Albert E. Ayoub 
 
 
The development of the cerebellar cortex is dependent on orchestrated cell-cell, 
cell-matrix interactions, as well as intrinsic genetic programs. Matrix metalloproteinases 
(MMPs) are proteolytic enzymes that degrade ECM molecules and are involved in 
neuronal migration, process extension, and synaptic plasticity. The current study 
investigated (1) the developmental expression and activity of MMP-2 and MMP-9, and 
(2) the effect of blocking the activity of MMP-2 and MMP-9 by a specific inhibitor on 
the histogenesis of the cerebellar cortex. Cerebella were collected from rat pups every 
three days starting at postnatal day 3 (P3) until P25 – a period equivalent to the third 
gestational trimester in humans. Temporal analysis of MMP activity by gelatinase assay 
showed that both the active and latent forms were present in the developing cerebellum. 
The mRNA analysis by real-time quantitative PCR indicated that the expression pattern 
of MMP-2 and MMP-9 mRNA agreed with their gelatinase activity. In situ zymography 
was localized in the EGL, the PCL, and IGL. The EGL, Bergamnn glial fibers, and the 
PCL showed immunoreactivity for MMP-2, whereas MMP-9 immunoreactivity was 
detected only in PC and the EGL. Exposure of organotypic slices to a specific MMP-
2/MMP-9 inhibitor (1.6, 3.2 or 6.4 µM) altered the activity of MMP-2 and 9 and caused a 
significant increase in the thickness of the EGL, and a decrease in migrating granule 
neurons in the molecular layer. Our study suggests that MMP-2 and MMP-9 play a role 
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Chapter One: Introduction 
 2
The development of the cerebellar cortex involves the timely generation of 
different types of cells with a precise connection pattern that produces highly conserved 
tissue architecture. The cerebellum develops from the rhombic lip on the roof of the 
fourth ventricle. Cells in the cerebellum are generated from two germinal zones – the 
ventricular germinal zone and the external germinal layer (Figure 1.1). Precursor cells in 
the ventricular germinal zone generate cerebellar neurons and glial cells starting with 
Purkinje cells around embryonic day 11 in rodents and embryonic day 55 in humans 
(Gilthorpe et al., 2002; Yachnis and Rorke, 1999). Progenitors of granule neurons 
migrate from the rhombic lip and form a thin external germinal layer that generate 
granule neurons during the first two postnatal weeks in rodents and the last trimester of 
human fetal development. The organization of the cerebellar cortex and its development 
are dependent on a myriad of intrinsic and extrinsic factors. The orchestration of the 
activity of genes, gene products, interactions among cells, and between cells and the 
extracellular matrix is crucial for neurogenesis, migration, and differentiation. Each of 
these developmental processes is vulnerable to disruption. Numerous gene mutations and 
neurotoxic agents are known to cause developmental abnormalities in the cerebellum by 
interfering with these processes (Ferguson, 1996; Millen et al., 1999). Analysis of 
mutations, like reeler and weaver, and toxin-induced abnormalities, like exposure to lead 
and methylmercury (Howard and Mottet, 1986; Lorton and Anderson, 1986), helped 
uncover an array of molecular and genetic mechanisms that drive the development of the 
cerebellum. 
The histogenesis of the internal granule layer has been extensively studied and is 
an excellent model to study neurogenesis, migration, process extension, and 
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differentiation. Progenitor cells in the external granule layer proliferate rapidly then 
migrate radially towards the ventricular zone and form the internal granule layer. As they 
descend, they extend two apical processes forming the parallel fibers that synaptically 
connect to the dendritic spines of Purkinje neurons. Granule neurons migrate through an 
already formed molecular layer, past the Purkinje cell layer and stop before reaching the 
white matter. Bergmann glial processes help guide the migration of granule neurons 
through the molecular layer. Extensive development of Purkinje cell dendritic trees and 
maturation of Bergmann glial processes occur during the same period. The molecules 
involved in remodeling the extracellular matrix for migrating granule neurons and 
extending processes are not well understood.  
Extracellular matrix-degrading enzymes, matrix metalloproteinases (MMP), have 
been studied in other systems and been shown to be involved in cell proliferation, process 
extension, migration and cancer metastasis. These enzymes are normally tightly regulated 
due to their potent proteolytic activity. Specific tissue inhibitors of matrix 
metalloproteinases (TIMPS) are expressed concomitantly with MMPs and regulate the 
activation of matrix metalloproteinases. Emerging evidence connects MMPs, especially 
MMP-2 and MMP-9, to events like normal brain development, tissue remodeling and 
various diseases and injuries affecting the central nervous system (Yong et al., 2001). For 
example, Vaillant et al (1999) showed that MMP-2 and MMP-9 are expressed in the 
cerebellum at postnatal days 10 and 15. However, the functional contribution and 
developmental expression and temporal activity of MMP-2 and MMP-9 in the developing 
cerebellar cortex are not known.  
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Figure 1.1 Formation of the cerebellar primordium. Progenitors of granule neurons 
migrate from the rhombic lip on the surface of the cerebellar primordium (curved arrows) 
and form the external granule layer (EGL) of Obersteiner.  
 
The central hypothesis of this investigation is that MMP-2 and MMP-9 contribute 
to the development of the rat cerebellar cortex, with the implication that the disruption of 
MMP-2 and MMP-9’s function would cause developmental abnormalities. The study 
tested the hypothesis by pursuing the following objectives: 1) localize and determine the 
temporal pattern of expression of MMP-2 and MMP-9 and their spatiotemporal activity 
in the developing cerebellum, 2) to determine whether blocking MMP-2 and MMP-9’s 
activation by a specific inhibitor hinders the proliferation and migration of granule cells.  






we performed an immunohistochemical study, real-time quantitative RT-PCR, and 
zymographic analysis on tissue collected from neonatal rats every 3 days from postnatal 
day 3 until postnatal day 25. Finally, we investigated the effect of inhibition on MMP-2 
and MMP-9 in an organotypic slice culture system. We measured the activity of these 
enzymes, the thickness of the external granule layer and the number of migrating cells in 
the molecular layer in thinly sectioned slices after exposure to a specific MMP-2/MMP-9 
inhibitor. 
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Chapter Two: Literature Review 
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A review of the structure and function of the cerebellum 
 
 The cerebellum contributes significantly to planning and coordinating movement, 
maintaining muscle tone and equilibrium, and motor learning and plasticity. Among 
cerebellar dysfunctions, motor disorders like dysmetria, dysdiadochokinesia and 
hypotonia are most prevalent. Several developmental and genetic disorders riddle the 
cerebellum such as Joubert’s syndrome (Yachnis and Rorke, 1999), Walker's 
lissencephaly and neu-laxova syndrome (Lyon et al., 1993). Ethyl alcohol consumption 
and exposure is also a major cause of damage to the cerebellum (Bendszus et al., 2001; 
Brodie, 2002; Tagliaferro et al., 2002; White et al., 2000a), especially during 
development (Bonthius et al., 1988; Bonthius and West, 1988; Cragg and Phillips, 1985; 
Olney et al., 2002; Pierce et al., 1999).  
 The cerebellum is located in the posterior cranial fossa below the dural tentorium 
cerebelli. The cerebellum constitutes part of the roof of the fourth ventricle. It lies behind 
the isthmus, the boundary between the midbrain and the hindbrain, and dorsal to the pons 
and medulla oblongata. The cerebellum is divided into a narrow medial portion called the 
vermis and two lateral hemispheres. Numerous transverse sulci create thin folia (leaflets) 
that extend over the entire external surface of the cerebellum (Conradi, 1985). Deeper 
fissures subdivide the surface of the cerebellum into lobules, which are grouped into three 
principal lobes -- anterior, posterolateral and flocculonodular. The flocculonodular lobe is 
the phylogenetically oldest part of the cerebellum and is called the archicerebellum. This 
division is primarily involved in maintaining equilibrium and is connected with the 
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vestibular system. The second oldest division of the cerebellum is called the 
paleocerebellum and contains the anterior lobe. This part maintains muscle tone and 
coordinates limb movements. The posterolateral lobe is considered the neocerebellum 
and is responsible for coordinating fine movements (Altman and Bayer, 1997; Whiting 
and Barton, 2003; Dillon and Atkins, 1970; Parma, 1969; Nieuwenhuys, 1967).  
  In the cerebellum, white matter lies below the cortical mantle and encapsulates 
four pairs of deep cerebellar nuclei. From medial to lateral, they are called the fastigial, 
the globose, the emboliform, and the dentate (Korneliussen, 1968). These nuclei receive 
output from the cerebellar cortex and collaterals from climbing and mossy fibers. Cortical 
projections to the deep nuclei are all inhibitory, GABAergic neurons, which originate in 
Purkinje cells. The dentate, emboliform, and globose send projections via the superior 
cerebellar peduncle to the red nucleus, ventral lateral and ventral posterolateral nuclei of 
the thalamus, other thalamic nuclei, and the contralateral inferior olivary nucleus. 
Efferent fibers from the fastigial nucleus target contralateral brain stem nuclei, various 
nuclei in the reticular formation, motor neurons in the upper cervical spinal cord, bilateral 
vestibular nuclei, superior colliculus, and ventral lateral and ventral posterolateral nuclei 
of the thalamus (Figure 2.1) [for more details refer to (Kandel et al., 2000; Altman and 
Bayer, 1997)].  
Three major pairs of fiber bundles connect the cerebellum to the rest of the 
nervous system. The superior cerebellar peduncle has cerebellar efferents to the thalamus, 
the red nucleus, vestibular nuclei, the reticular formation, the oculomotor nucleus, and 
contains a few afferent fibers from the spinal cord. The middle cerebellar peduncle 
contains efferents from contralateral pontine nuclei, while the inferior cerebellar peduncle 
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links the cerebellum with the inferior olive, brain stem nuclei, vestibular nuclei and the 
spinal cord (Carpenter, 1991; Altman and Bayer, 1997; Hayle, 1973; Jansen, 1972; Ito, 
1968; Eccles, 1967).  
 
Figure 2.1  An illustration of the major cerebellar pathways. Refer to the text for 
description. (Ctx: cortex; D: dentate nucleus; DSCT: dorsal spinocerebellar tract; E: 
emboliform; F: fastigial; G: globose; ICP: inferior cerebellar peduncle; IO: inferior olive; 
MCP: middle cerebellar peduncle; SCP: superior cerebellar peduncle; VSCT: ventral 
spinocerebellar tract; WM: white matter) (adapted from Carpenter, 1991). 
  
The organization of the cerebellar cortex is noticeably conserved among 
vertebrates, especially with regard to the connection pattern among cortical neurons 
(Lange, 1971; Lange, 1972; Nieuwenhuys, 1967). However, the ratio of granule neurons 
to Purkinje neurons increases with evolutionary advancement (Han and Bell, 2002; 
Glickstein and Voogd, 1995; Hayle, 1973; Schleifenbaum, 1973; Kanan, 1973; 













molecular layer, a Purkinje cell layer, and an internal granule layer (Figure 2.2 A and B) 
(Obersteiner H, 1883; Addison, 1911; Cajal, 1909; Palay and Chan-Palay, 1974; Rakic 
and Sidman, 1970; Jansen, 1972; Hackethal, 1971). 
 
Figure 2.2 Histology of the cerebellum. An illustration of a cerebellar folium. Granule 
neurons extend parallel fibers along the long axis of the folium. They synapse with the 
dendrites of Purkinje cells. Also shown are BC: Basket cell; CF: Climbing fibers; GC: 
Golgi cell; gr: granule neuron; Gran: Internal granule layer; MF: Mossy Fibers; Mol: 
Molecular layer; Pur: Purkinje cell; PF: Parallel fiber; SC: Stellate Cell. [from:(Jacobson, 
1991)]. 
 
The molecular layer in the adult animal contains stellate cells, basket cells, the 
unmyelinated parallel fibers of granule cells, a small population of astrocytes, Bergmann 
glia and the immense dendritic trees of Purkinje neurons (Cajal, 1909; Rakic, 1971; 
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Goldowitz and Hamre, 1998). Several extracellular matrix molecules have been found in 
the granule and molecular layer, including chondroitin sulfate, laminin, versicans, 
cytotactin, tenascin-R, hyaluronic acid and hyaluronic acid-binding proteins, and 
thrombospondin (Bandtlow and Zimmermann, 2000; Bignami et al., 1993a; Bignami et 
al., 1993b; Grumet et al., 1985; Llano et al., 2000; Loeb and Fischbach, 1995; O'Shea et 
al., 1990). Mounting evidence suggest that these molecules play an important role in the 
formation of the cerebellum. For example, abnormal positoning of neurons and glia in the 
cerebellum and cerebral cortex is observed in animals suffering from a mutation to the 
extracellular protein reelin (Bignami and Dahl, 1974; Yuasa et al., 1993).  
Purkinje neurons are the first neurons to reach in the cerebellar cortex right below 
the thin external germinal layer of Obersteiner, where they aggregate in a three to four-
cell layer (Athias, 1897; Yuasa et al., 1991). After birth in rodents, Purkinje cells 
progressively begin to align in a one-cell layer and their dendrites start to grow from 
small bifurcated stumps into branched dendritic trees (Addison, 1911; Altman and Bayer, 
1985). As the dendritic trees begin to receive parallel fibers from migrating granule cells, 
they grow and begin to flatten in a plane perpendicular to the long axis of the folium. In 
the adult, the Purkinje cell layer has a single row of Purkinje cell somata. The dendrites 
of Purkinje cells receive climbing fibers arising in the contralateral inferior olive and axo-
dendritic excitatory connections from parallel fibers. Purkinje cells synthesize γ-
aminobutyric acid as a neurotransmitter and their axons constitute the only output of the 
cerebellar cortex. Purkinje cells express a variety of molecules including the calcium-
binding protein calbindin D28k , the NgCAM-binding protein FAR-2, and the cell 
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adhesion molecule Tenascin-R (Amenta et al., 1994; Plagge et al., 2001; Woodworth et 
al., 2002). 
  Bergmann glia, also called Golgi epithelial cells, have their cell bodies 
surrounding the Purkinje cell somata (Shiga et al., 1983; Reichenbach et al., 1995). 
Bergmann glial cells extend processes through the molecular layer to reach the pial 
surface. These processes are believed to help guide the migration of granule neurons 
during development. Bergmann glial fibers persist into adulthood and their membranes 
become closely apposed to Purkinje cell dendritic spines (Figure 2.3) (Castejon, 1990; 
Spacek, 1985). Several groups studied the relationship between Bergmann glia and 
Purkinje cells, which led to the proposition that Bergmann glia help with the metabolic 
demands of Purkinje cells. For example, the enzyme 3PGDH, which is required for the 
biosynthesis of several membrane proteins, nucleotides, and the neuroactive peptide 
glycine is expressed in Bergmann glia, but not in Purkinje cells (Yamasaki et al., 2001). 
Furthermore, Bergmann glia express the Ca2+-permeable AMPA-type glutamate receptor 
(Iino et al., 2001). This receptor is indispensable for the removal of glutamate released at 
synaptic clefts between climbing fibers and Purkinje cells. Mounting evidence suggests 
that Bergmann glia in the adult cerebellum fulfill a role similar to that of astrocytes 
(Yamasaki et al., 2001; Iino et al., 2001; Seil, 2001; Yuasa et al., 1996; Hatten, 1984; 




Figure 2.3 Relationship between Bergmann glia and Purkinje neurons. A Drawing 
depicting the relationship of Bergmann glia to Purkinje cells in the rat cerebellar cortex. 
In the second and third postnatal weeks, the external granule layer diminishes in 
thickness due to cell migration and cell death. As Purkinje cells mature and their 
dendritic trees grow, Bergmann glial processes increase their coverage of Purkinje 
dendrites and begin to fulfill a role similar to that of astrocytes. PC: Purkinje cell; BG: 
Bergmann Glia; BGF: Bergmann Glial fibers; EGL: external granule layer. 
 
   Granule neurons are tightly packed in the internal granule layer. These neurons 
form the parallel fibers that comprise most of the molecular layer in the adult animal. 
Parallel fibers run in a parallel direction to the long axis of the folium. In this 
configuration they run in a perpendicular path to the dendritic trees of Purkinje cells 
(O'Leary et al., 1968). In humans, more than 400,000 parallel fibers are thought to 
intersect and synapse with each Purkinje cell dendritic tree (Jansen, 1972). Parallel fibers 
also make excitatory synapses with the dendrites of stellate cells, basket cells, and Golgi 
type II neurons (see below). Lugaro cells are located just below the Purkinje cell layer 
and send their process upward into the molecular layer, where they connect with basket 







Another type of interneurons in the internal granule layer is the unipolar Brush cells. 
These receive excitatory collaterals from mossy fibers and synapse with granule neurons 
in the internal granule layer (Dino et al., 2000a; Dino et al., 2000b). Golgi cells are 
dispersed among the granule neurons in the internal granule layer and in much smaller 
numbers. Their axons meet with the claw-like axonal endings of granule neurons and the 
terminal endings of mossy fibers  The intersection of the three axonal endings is 
ensheathed by a glial capsule to form a glomerulus (O'Leary et al., 1968; Mugnaini and 
Forstronen, 1967; Eccles et al., 1967). Several hypothesis [reviewed in (Kandel et al., 
2000)] have been proposed to explain the countless computations performed by the 
cerebellar circuitry, which permit the coordination of muscle movement and the 
maintenance of balance. Most importantly, the development of these circuits is essential 
to proper motor movements, which if disturbed can siginificantly affect the functioning 
of the organism as a whole. 
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Cerebellar corticogenesis: with emphasis on the ontogenesis of granule 
neurons and the contribution of the ECM 
 
 The development of the cerebellar cortex has been extensively described in 
several species by Obersteiner (1883), Cajal (1911), Addison (1911), and Miale and 
Sidman (1961) to name but a few. The formation of the cerebellar primordium starts 
around embryonic day 55 in human fetuses and embryonic day 11 in rodents (Sidman and 
Rakic, 1973; Altman and Bayer, 1985) and continues until the postnatal period. The 
ventricular germinal zone at the edges of the rhombic lip, between rhombomere 1 and 2, 
generates the precursors of deep cerebellar neurons as a first wave, followed by the 
generation of the precursors of Purkinje cells and of Bergmann glia (Figure 2.4). The 
latter two types populate the mantle layer. Golgi type II neurons, basket cells, and stellate 
cells are generated afterwards. Golgi type II neurons settle in the internal granule layer, 
whereas the basket cells and stellate cells settle in the molecular layer. Astrocytes and 
oligodendrocytes are generated later during the development.  
A restricted region in the ventricular zone of the rhombic lip generates precursors 
that form the external granule layer of Obersteiner. Neuroblasts migrate dorsomedially on 
the surface of the cerebellar anlage and form the one-layer-thick external germinal zone 
(Gilthorpe et al., 2002). This layer generates the mature granule neurons that populate the 
internal granule layer. Purkinje neurons are generated long before granule neurons. 
Purkinje cells first aggregate to form a thick layer below the external germinal zone. By 
the time granule neurons start to migrate, Purkinje cells have already aligned themselves 
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in a single-cell layer. In newborn rats, the dendritic tree of Purkinje cells is limited to a 
few branches.  
The differentiation and growth spurt of the Purkinje dendritic trees occur during 
the period of migration of granule neurons (Addison, 1911; Altman, 1972a; Zecevic and 
Rakic, 1976), which takes place between postnatal day 4 (P4) and P20 in the rat, and 
between the 4th fetal month and the end of the 1st postnatal year in humans. The 
relationship between the growth of the Purkinje dendritic tree, and the migration of 
granule neurons and the formation of parallel fibers was noted by Cajal (Cajal, 1909), 
who proposed an interdependence between these cells. Indeed, destruction of the external 
granule layer, as in x-irradiated neonatal rats, results in underdeveloped Purkinje 
dendrites (Altman et al., 1969b; Altman et al., 1969a); whereas the destruction of 
Purkinje neurons causes a comparable loss of granule neurons. Purkinje neuron somata 
receive synapses from climbing fibers from the contralateral inferior olive. In human 
fetuses, these fibers initially aggregate in a cell-free layer called the lamina dissecans 
before contacting Purkinje neurons. As the Purkinje dendritic trees grow and branch, 
climbing fibers start to synapse with the apical dendrites (Rakic and Sidman, 1970). Later 
during development, basket cells extend processes and surround Purkinje somata with an 
array of fibers that resemble baskets. 
 The lamina dissecans is a thin acellular layer composed of cytoplasmic 
outgrowths from immature Purkinje cells and granule neurons. Axonal endings of mossy 




Figure 2.4 Cerebellar histogenesis. Starting at embryonic day 9 (E9), the cerebellar primordium is composed of a marginal layer (a) 
and a mantle layer (b). By E13, precursor cells in the internal germinal zone (d) start generating cerebellar cells, and cells from the edge 
of the rhombic lip migrate to the surface of the cerebellar anlage and form the external germinal layer of Obersteiner (c). Between E14 
and P3, immature neurons migrate to form deep cerebellar nuclei (e) followed by Purkinje neurons (f) and Bergmann glia (g). Around 
the time of birth, interneurons (h) -- Golgi type II, stellate, and basket cells -- settle in the cerebellar cortex. By P3, the EGL increases in 
thickness due to proliferating progenitor cells (i). During the same period, Purkinje neurons line up and form a one-layer thick Purkinje 
cell layer. Postmitotic granule neurons start to migrate by P6 (j, k) and descend through the molecular layer and settle in the IGL. 
Granule neurons extend parallel fibers (k) as their nuclei translocate centipitally. They maintain close association with Bergmann glial 
fibers. Purkinje cell dendrites mature (l) as they receive synaptic contacts from granule neurons. By postnatal day 20, the EGL 
disappears and granule neurons form the internal granule layer. The development of the cerebellar cortex is near completion as 
myelination begins (n). 
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developing human fetus by week 21 and disappears by week 30 (Rakic and Sidman, 
1970). This layer has been demonstrated in cetaceans (blue whale) (Korneliussen, 1967) 
and is thought to exist in primates, but not in other vertebrates. Rakic and Sidman (1970) 
proposed that afferent fibers occupy and form this layer during their wait to receive their 
targets. It is possible that afferent fibers are supplied with trophic support that prevents 
their degeneration for several weeks, as well as a “stop” signal that halts their progress 
before reaching the Purkinje cell layer. The mechanisms and signals that might contribute 
to the formation of this layer are unknown.  
 Bergmann glia, also called Golgi epithelial cells, were described by Bergmann 
(1857), Golgi (1885), Athias (1897), Cajal (1911) and later by Miale and Sidman (1961), 
Gobel (1967), Mugnaini (1967), Rakic (1971), Palay and Chan-Palay (1974) and others. 
These cells are generated early during development in the ventricular zone and take on a 
radial orientation. A small number of these cells move to the mantle layer by embryonic 
day 14 in the mouse, as described from in situ hybridization, and immunohistochemistry 
for tenascin and the glutamate transporter GLAST (Bartsch et al., 1992; Yuasa, 1996; 
Yamada et al., 2000; Yamada and Watanabe, 2002). Once in the mantle layer, they 
extend long fibers that terminate as conical end-feet that make contact with the pial 
surface. These cells form a dense layer below the Purkinje cell layer, and after birth move 
to position themselves among the Purkinje cells. During the first two postnatal weeks in 
the rat, Bergmann glial cells appear to continue their proliferation (Das, 1976). 
Furthermore, they continue to form a scaffold through their processes that facilitate the 
migration of granule neurons (Das et al., 1974; Das, 1976). Immature granule neurons 
start to differentiate and migrate centripetally in a close association with the Bergmann 
 19
glial fibers (Rakic, 1971). In electron microscopy, the membranes of glial fibers appear 
tightly attached to the spindle-shaped migrating neurons. Evidence presented from in 
vitro experiments and time-lapse video microscopy suggests that a mechanism more 
complex than just sliding is in effect in these migratory granule neurons (Edmondson and 
Hatten, 1987; Hatten M, 1990). Intracellular cytoskeletal organization is evident by the 
formation of a shell of microtubules that extends to the tip of the leading process and 
allows for vesicle trafficking. Furthermore, cortical actin wraps the nucleus and extends 
into the filopodia and the leading process. Migrating neurons form temporary junctions, 
called “interstitial densities”, with the glial fiber (Gregory et al., 1988). The connecting 
densities associate closely with the microtubular system and seem to differ from 
desmosomes seen in stationary neurons. During the first twenty postnatal days, 
Bergmann glia increase their membrane appositions with developing Purkinje dendrites. 
The surface in contact with Purkinje dendrites and budding spines appears more complex 
and dense than the surface in contact with migrating granule neurons. Bergmann fibers 
extend GLAST-positive digitations that progressively cover Purkinje cell dendrites 
(Yamada et al., 2000). Following the cessation of granule neuron migration, Bergmann 
glia gradually assume a role similar to that of protoplasmic astrocytes (Spacek, 1985). 
 The formation of the internal granule layer from the external germinal zone was 
initially described using the Golgi impregnation method (Obersteiner H, 1883; Addison, 
1911; Cajal, 1909). Further support emerged in the mid 1960s with the use of 
autoradiography (Miale I and Sidman R, 1961; Hanaway J, 1967; Altman, 1972a). Even 
though some evidence suggests that Golgi cells and basket cells, as well as granule 
neurons, are generated from the external granule layer (Hausmann et al., 1985), recent 
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evidence suggests otherwise. Clonal analysis using retroviral probes in chicks and rats 
allowed the determination of detailed lineage maps and provided additional support for 
the hypothesis that only granule neurons originate in the EGL (Ryder and Cepko, 1994; 
Zhang and Goldman, 1996b; Zhang and Goldman, 1996a). Ryder and Cepko (1994), 
followed later by Zhang and Goldman (1996), injected retroviruses carrying the β-
Galactosidase gene in the developing cerebellum at various ages and provided direct 
evidence for the origin of granule neurons. Injections in the EGL labeled progenitor cells 
that matured to become granule neurons only, whereas injections in the white matter 
labeled glial cells, basket, stellate and Golgi neurons. It is now accepted that neurons in 
the cerebellar cortex are generated from two germinal zones via opposing modes of 
migration. An outward migration from the ventricular zone generates all the neurons and 
glia of the cerebellar cortex, except the granule neurons. The later neurons are generated 
in the external germinal layer and migrate inwardly to populate the internal granule layer.  
  Ramon ý Cajal (1911) treated the developmental stages of granule cells in great 
length and tallied the knowledge learned from his contemporaries. According to Cajal, 
the maturation of granule neurons encompasses four developmental phases (Figure 2.5). 
The outermost zone in the external granule layer (of Obersteiner) contains proliferating 
undifferentiated progenitor cells. The deeper zone of the external granule layer contains 
fusiform bipolar cells that extend tangential parallel processes. These cells are postmitotic 
and pre-migratory. Progressively these cells descend into the plexiform or molecular 
layer. The third phase, the Radial Bipolar Stage, contains cells with fully extended 
processes. A dendrite protrudes from the cell body and extends centripetally towards the 
Purkinje cell layer. The nucleus translocates downward following the leading tip of the 
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dendrite until it reaches the internal granule layer. Thus, the parallel fibers or axons of 
granule cells are fully developed by the time the cells reach their destination. When 
granule cells pass the Purkinje cell layer, their leading dendrite is resorbed and replaced 
with several thin dendrites that emanate from their perikarya in all directions. Only three 
or four of these dendrites develop varicosities as they start receiving mossy fiber rosettes. 
These dendritic varicosities eventually develop into claw-like digitations. 
 
 
Figure 2.5 A schematic representation of the developmental stages of granule 
neurons by Ramon ý Cajal (1911). Progenitor cells proliferate rapidly in the EGs. 
Daughter cells assume a pre-migratory phenotype (c) in the EGd and start growing 
parallel processes. As granule neurons move through the molecular layer (d), they extend 
their parallel process and make synaptic contacts with Purkinje cell dendrites. A leading 
process extends from the forward tip of the granule cell (e, f) and crawls towards the 
internal granule layer. The nucleus translocates down (g, h), past the Purkinje cell layer 
and settles in the internal granule layer. The cell differentiates further and grows claw-
like dendrites that receive mossy fibers (i, j). Abbreviation: EGs, superficial external 
granule layer; EGd, deep external granule layer; Mol, molecular layer; Pur, Purkinje cell 
layer; IG, internal granule layer. 
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The advent of molecular biology has helped shed light on the molecular 
machinery that drives this process. An internal genetic clock has been proposed to dictate 
the migration of granule neurons (Trenkner et al., 1984; Zagon et al., 1985; Komuro and 
Rakic, 1995). Indeed, there is growing evidence in support for an intrinsic genetic 
program with the potential to maneuver the migrating granule neurons in a time and age 
dependent manner (Komuro and Rakic, 1995; Komuro and Rakic, 1998; Komuro et al., 
2001). Recently, Yacubova and Komuro (2002) showed in an elegantly designed set of 
experiments that cultured granule neurons exhibit sequential alterations in morphology 
and migratory behavior in the absence of ECM signaling (Yacubova and Komuro, 2002). 
The observed movements, however, did not perfectly mimic those normally observed in 
vivo, which suggests a role for extracellular signals and cell-cell interactions. Hausmann 
and Sievers (1985) showed that granule neurons in vivo maintain contact with the basal 
lamina during their proliferative phase. They observed that proliferating cells in the 
superficial EGL make contact with the basal lamina through their soma or with short 
radial processes from embryonic day 16 until postnatal day 17 (Hausmann and Sievers, 
1985). Growing evidence supports a role for the extracellular matrix and extracellular 
signaling in addition to the innate genetic program. For example, Hager et al (1995) 
reported that granule neurons in organotypic cerebellar slices can migrate centripetally 
with or without contact with glial elements (Hager et al., 1995). A follow-up study by the 
same group showed the involvement of the extracellular molecule laminin in the 
migration process. Blocking the activity of laminin with a specific antibody against the 
B2 chain of laminin in living cerebellar slices inhibited neuronal migration (Liesi et al., 
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1995). Additionally, laminin interacts and enhances the mitogenic effect of Sonic 
hedgehog (Shh) signaling on proliferating granule neurons in vitro (Pons et al., 2001). 
 The proliferation of granule progenitors in the sEGL has been shown to be 
induced by Purkinje cells through Shh signaling (Wallace, 1999). Secreted Shh causes the 
progenitor cells in the sEGL to upregulate the transcription factors Gli1 and Gli2 
(Dahmane and Altaba, 1999), a mechanism that promotes proliferation and inhibits 
differentiation (Rowitch et al., 1999). ECM molecules like HSPG, laminin and 
vitronectin, regulate the response of granule progenitors to Shh. HSPG and laminin 
enhance Shh-induced proliferation of granule progenitors (Pons et al., 2001; Rubin et al., 
2002), whereas vitronectin induces cell-cycle exit and differentiation (Wechsler-Reya, 
2001). Vitronectin stimulates differentiation through the c-AMP/CREB signaling cascade 
(Pons et al., 2001; Wechsler-Reya, 2001). 
We are just beginning to understand the role that interactions with the 
extracellular environment play in the shaping of the nervous system. The extracellular 
matrix is a product of its inhabitants and seems to affect their behavior dramatically. 
Several extracellular molecules emerged as modulators of cell behavior like laminin, 
proteoglycans, integrins, reelin, tenascin, cytotactin, hyaluronic acid and matrix 
degrading enzymes (Grumet et al., 1985; Werz and Schachner, 1988; Bignami et al., 
1993a; Pires Neto et al., 1999; Bandtlow and Zimmermann, 2000; Pesheva and 
Probstmeier, 2000; Schwartz, 2001; Del Bigio et al., 1999). Proteoglycans are large 
glycoproteins that form a main component of the extracellular matrix in all tissues 
including the brain. Some proteoglycans, like neurocan, versican v2, brevican and 
neuroglycan, are secreted exclusively in the CNS by neurons or glial cells. Others are 
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available in other tissues like syndecans, NG2, agrins and testicans. These molecules bind 
to a plethora of molecules including growth factors, cell surface molecules, adhesive and 
repellent molecules, and other constituents of the ECM such as laminin, tenascin, 
fibronectin and thrombospondin (Bandtlow and Zimmermann, 2000; Bruckner and 
Grosche, 2001; Ohtsuka et al., 2000; Oohira, 2001; Sobel, 2001).  The distribution 
pattern of proteoglycans (e.g. glypican 1 and NG2) during development points to their 
direct involvement in neurogenesis and gliogenesis, axonal pathfinding and 
differentiation.  
 Some ECM molecules, like hyaluronic acid, went unnoticed for a long time 
because they readily dissolve during tissue preparation. Hyaluronic acid exerts its 
influence partly through hyaluronic-acid-binding proteins (HA-BP) like versicans, 
aggrecans, and the glial HA-BP (Bignami et al., 1993a; Bignami et al., 1993b). ECM 
molecules bind adhesive and repellant molecules and modulate their function. For 
example, Ng-CAM and cytotactin are expressed in migrating granule cells and glial cells 
respectively (Chuong et al., 1987).  Anti-Ng-CAM antibodies arrest migratory granule 
neurons in the external granule layer, whereas anti-cytotactin antibodies arrest granule 
neurons in the molecular layer. The adhesive function of Ng-CAM and cytotactin is 
promoted by chondroitin sulfate proteoglycans, but inhibited by heparin and heparan 
sulfate (Milev et al., 1995; Werz and Schachner, 1988; Hoffman et al., 1988). 
Conversely, in peripheral nerves and DRG neurons, chondroitin sulfate proteoglycans 
inhibit laminin-stimulated neurite growth (Zuo et al., 1998). This effect can be reversed 
in vitro by the addition of recombinant MMP-2, a matrix-degrading enzyme also thought 
to be expressed in the cerebellar cortex. Another example is netrin-1 which acts as an 
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attractant to growth cones and changes to repulsion when it binds laminin-1 (Hopker et 
al., 1999). Another adhesion molecule, astrotactin 1, is expressed in migrating neurons in 
the cerebellum. This molecule is involved in the formation of temporary junctions 
between the leading process of migrating neurons and glial cells (Adams et al., 2002; 
Zheng et al., 1996). In vitro assays show that blocking astrotactin with specific antibodies 
caused a significant 60% decrease in the migration rate of granule neurons (Fishell and 
Hatten, 1991).  
Thrombospondin (TSP), is a trimeric glycoprotein that is expressed at the 
neuromuscular junction and around synapses in the retina and the adult cerebellum 
(Arber and Caroni, 1995). Thrombospondin is first apparent in the rhombic lip and 
contributes to the formation of the external germinal zone (O'Shea et al., 1990). TSP 
appear to be involved in the initial interactions between leading axons of granule cells 
and Bergmann glial cells, to promote neurite outgrowth and help mediate the migration of 
granule cells across the molecular layer in explants of neonatal cerebellum. Activation of 
cellular events by TSP-1 is thought to involve the extracellular receptor Integrin alpha 3 
beta 1 (DeFreitas et al., 1995). Studies on the function of thrombospondins in 
neovascularization and tumor metastasis show that TSP-1 upregulates the matrix 
degrading enzyme MMP-9 (Albo et al., 2002; Qian et al., 1997). The intermediate steps 
may include signaling via cell surface receptors like integrins but are not clear at the 
present time. 
 The effect of several soluble and insoluble ECM molecules is exerted through the 
integrin family of cell surface receptors. Integrins have extracellular domains that bind 
extracellular molecules, transmembrane domains, and an intracellular domain involved in 
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cell signaling (Damsky and Werb, 1992; Schwartz, 2001). The binding of integrins to the 
ECM is relatively weak and allows for rapid formation and dissociation of contacts, 
which are necessary processes in cell migration. Integrins associate with growth factor 
receptors and are thought to modulate and potentiate their downstream signaling (Eliceiri, 
2001; Martin et al., 2002). Binding of integrins to ECM molecules, like fibronectin and 
laminin, results in the rapid phosphorylation of FAK (focal adhesion kinase) and Src 
proteins (nonreceptor protein-tyrosin kinases). Phosphorylation of the SH2 domain of 
FAK induces the PI-3K signaling pathway and recruits the Grb2-Sos complex, which 
activates the Ras-ERK-MAP kinase signaling cascade. More than 20 proteins, including 
vinculin and myosin II, are thought to associate with the cytoplasmic domain of integrins. 
These molecules help trigger the reorganization of the actin cytoskeleton and the 
formation of stress fibers in motile cells. Motility requires the dissociation of connections 
between integrins and their ECM ligands. This process is facilitated by de-adhesive 
molecules like disintegrins, ADAMs (a disintegrin and metalloproteinase), and 
ADAMTSs (ADAM with thrombospondin repeats). Disintegrins have binding motifs that 
block the interactions with ECM molecules and can sequester matrix metalloproteinases 
that degrade the ECM (Shrimali and Reddy, 2000; Wu et al., 2003). ADAMs are 
membrane-anchored disintegrins that catalyze the breakdown of ECM and membrane 
molecules in the vicinity of the cell surface (Huang et al., 2003; Fourie et al., 2003). 
ADAMTS have a structure similar to ADAMs except they have thrombospondin-1 like 
repeats (Tang, 2001). Proteolytic cleavage of extracellular domains allows the cell to 
control the activity of membrane receptors and release factors. For example, the ADAM 
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member TACE (TNF-α converting enzyme) can release the inflammatory cytokine TNF-
α from the cell surface (Moss and Lambert, 2002). 
 Autocrine and paracrine diffusible factors like neurotrophins and cytokines have 
been shown to be involved in various aspects of CNS development. In the cerebellar 
cortex, neurotrophins promote cell differentiation, proliferation, and inhibit cell death 
(Vaudry et al., 2003). IGF-1 (insulin-like growth factor 1) is secreted by Purkinje cells 
and exerts such a trophic effect on granule cells. IGF-1 triggers the phosphoinositide 3-
kinase (PI-3k), which phosphorylates Akt and upregulates survival signaling (D'Mello et 
al., 1993; Bonthius et al., 2003). Glutamate released at synapses also activates the PI-
3k/Akt pathway and enhances the survival of differentiating cells. On the other hand, 
glutamate has an opposite effect on mature granule neurons; glutamate can activate the 
p38-Rb, which in turn activates caspase-3 death signaling (Felici et al., 1989).  Some 
cytokines like TGF-β and TNF-α act as death signals by activating the JNK-p53 
pathway, which results in the activation of caspase-3 and the initiation of cell death. Bone 
morphogenic proteins -- BMP-4, 6 and 7 – are also members of the TGF-β family, are 
expressed in the postnatal cerebellum and are thought to promote differentiation (Ming et 
al., 2002; Yabe et al., 2002; Alder et al., 1999). BMP binding to cell surface receptors 
induces the phosphorylation of smad1 and its association to smad-4. The smad1/smad4 
complex translocates to the nucleus activating genes involved in cell differentiation 
(Angley et al., 2003).  
 The growth factor Neuregulin, secreted by neurons in the cerebellum (Chen et al., 
1994), affects their migration, and induces the maturation of glial radial process (Ozaki et 
al., 1998; Rio et al., 1997) and the formation of synapses between mossy fibers and 
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granule neurons (Ozaki et al., 2000). Blocking the interaction of neuregulin with its 
receptor erbB4 in vitro causes impairment in the development of glial radial fibers and 
the migration of granule neurons. Furthermore, differential expression of the neuregulin 
receptors -- erbB-1, -2, -3, -4 and NRG beta-1-- by granule neurons and other cells in the 
cerebellum may promote proliferation or differentiation. The receptors erbB-2 and -1 are 
not normally expressed in the EGL. The erbB-3 receptor is observed in postmitotic cells, 
whereas erbB-4 is thought to inhibit differentiation (Pinkas-Kramarski et al., 1997). In 
medulloblastoma, a tumor of the EGL, a deregulated expression of the erbB-2 receptor, 
which is normally absent in the EGL, and the erbB4/NRG beta-1 is thought to promote 
tumorigenesis and metastasis (Gilbertson et al., 1998).  
 Neurotrophins have varying effects on granule neurons in the cerebellum 
depending on their developmental stage. BDNF, NT-4 and NT-5 promote the survival of 
immature granule progenitors (Yacubova and Komuro, 2003; Dieni and Rees, 2002; 
Borghesani et al., 2002; Carter et al., 2002). The PI-3k pathway, via the PLC-γ and the 
SHC-Ras-Raf pathway, mediates the trophic effect of BDNF, NT-4, and NT-5. The latter 
two pathways activate the MAPK cascade, which results in the phosphorylation of 
transcription factors in the nucleus and the initiation of gene translation. On the other 
hand, NT-3 seems to promote cell cycle exit and the differentiation of granule cells 
(Seabold et al., 1998; Condorelli et al., 1998; Maisonpierre et al., 1990).  In various 
cases, it is becoming apparent that neurotrophin signaling in vivo is enhanced by integrin 
signaling, thus affecting the organization of the cytoskeleton, cell motility, cell cycle 
regulation, as well as survival and differentiation (Mills et al., 2003; Martin et al., 2002) . 
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A considerable understanding of the morphogenesis of the cerebellar cortex and 
the interdependence of cells has been learned from studies of mutant mice. To date, about 
fifty mutations have been identified that result in aberant development and a spectrum of 
clinical deficits. A comprehensive review of mutations affecting the cerebellum is beyond 
the scope of this discussion [reviewed in (Sotelo, 1990; Goffinet, 1990; Katsuhiko et al., 
1984; Sidman, 1983; Caviness, Jr. and Rakic, 1978; Landis and Landis, 1978)]. Of 
particular interest is the mutation affecting the extracellular protein reelin in reeler mice 
(D'Arcangelo et al., 1997). Reeler mutants have abnormal patterning and neuronal 
positioning in laminated structures of the CNS, including the cerebral cortex, 
hippocampus, the dorsal cochlear nucleus, the inferior olivary complex, and the 
cerebellar cortex. Purkinje neurons in the cerebellum of reeler mice are ectopically 
located and reduced in number (Yuasa et al., 1993; Heckroth et al., 1989), and so are 
granule neurons and Bergmann glia (Terashima et al., 1985; Bignami and Dahl, 1974). 
Despite the disorderly arrangement of cells in the cerebellar cortex, the synaptic 
connections appear normal between synaptic partners.  
Reelin is expressed in pioneering neurons and forms an integral part of the 
cortical matrix (cortical plate) (Tissir et al., 2002). Reelin binds the membrane receptors 
VLDLR (very-low-density lipoprotein) and ApoER2 (apolipoprotein E receptor type 2), 
which phosphorylate the cytoplasmic protein Dab1 (disabled-1) and trigger presently-
unknown signaling cascades (Rice et al., 1998; Howell et al., 1997). Interestingly, 
mutations affecting the genes of both receptors VLDLR and ApoER2, as well as the 
cytoplasmic protein Dab1, cause abnormalities similar to those observed in reelin mutant 
mice (Trommsdorff et al., 1999; Ohshima et al., 2001). The sequencing of genes and 
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identification of gene products of the reeler and other cerebellar mutants, like the weaver 
mutant, will provide additional insight about the mechanisms contributing to the 
histogenesis of the cerebellar cortex. 
 The cerebellar cortex is a marvelous processing powerhouse that easily outpaces 
any available manmade superprocessor. The microstructure of the cerebellum has been 
known since the beginning of the twentieth century, but the molecular machinery that 
pieces it together is largely unknown. Evidence is accumulating in support for both an 
intrinsic genetic machinery, as well as intercellular and intracellular signaling molecules. 
New work is unraveling the role of extracellular-matrix molecules and the mechanisms 
cells use to degrade and reconstruct the extracellular matrix. For a developing cerebellar 
cortex, remodeling the extracellular matrix is a balance between proteolysis and synthesis 
that facilitates cell migration and process extension, yet holds all cellular elements 
together. Close proximity allows for intercellular communication and triggers more 
downstream events, events that culminate in the formation of the highly specialized 
circuits of the cerebellar cortex.  
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Matrix metalloproteinases and the extracellular matrix in the CNS 
 
 The extracellular matrix contributes to the integrity of the CNS, although not as 
extensively as other tissues like bone and cartilage. The extracellular matrix contains 
invaluable structural and signaling molecules needed for proliferation and differentiation, 
but too rigid and invariable a matrix would hinder developmental and homeostatic 
mechanisms like cell migration, neurite extension, and synaptic plasticity. Fortunately, 
the same cells that secrete extracellular matrix proteins secrete proteolytic enzymes that 
degrade them. This allows for tissue remodeling around extending neurites and filopodia, 
permitting the establishment of new connections as well as cell motility. As one can 
envision, the proteolytic activity of matrix-degrading enzymes has to be precisely 
controlled such that the enzyme is active only in front of growth cones, for example, and 
not at sites of attachment with the basal lamina. Matrix metalloproteinases are zinc-
dependent endopeptidases that degrade all extracellular molecules. Their activity is 
regulated at various levels by activators and inhibitors. Over 24 MMPs have been 
classified to date and seven have been found to be expressed in the nervous system. The 
expression of MMP-1 (Agapova et al., 2001; Schutz et al., 2002), MMP-2 (Costa et al., 
2002; Rosenberg et al., 2001), MMP-3 (Vaillant et al., 1999; Oh et al., 1999), MMP-7 
(Rosenberg et al., 2001; Conant et al., 1999), MMP-9 (Conant et al., 1999; Tanney et al., 
1998), MT1-MMP (Tanney et al., 1998; Agapova et al., 2001), MT5-MMP (Sekine-
Aizawa et al., 2001; Llano et al., 1999) and their inhibitors, TIMP-1 through 4, have been 
observed in normal CNS development and in pathological conditions. The expression of 
MMPs in the CNS does not appear to be cell-specific but function-specific. For example, 
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glial cells as well as neurons in various regions of the CNS express MMP-2 and MMP-9 
during process or neurite outgrowth (Costa et al., 2002; Ferguson and Muir, 2000; Oh et 
al., 1999; Uhm et al., 1998).  
 Numerous studies found that abnormal expression (over- or under-expression) 
and uncontrolled activity of MMPs accompanies various CNS pathologies like 
Alzheimer’s disease, aneurisms, ischemia/reperfusion, multiple sclerosis, 
meningioencephalitis, disruption of the blood-brain barrier, and Wallerian degeneration 
(Khuth et al., 2001; Vecil et al., 2000; Yoshiyama et al., 2000; Leib et al., 2000; Azeh et 
al., 1998; Planas et al., 2000; Clark et al., 1997; Gokaslan et al., 1998; Liuzzi et al., 2000; 
Fujimura et al., 1999; Rosenberg et al., 1996; Matsuura et al., 2000; Rosenberg et al., 
1998; Lim et al., 1997; Hughes et al., 2002; Maquoi et al., 2002). Outside the nervous 
system, MMPs have been studied extensively in bone remodeling, nephrogenesis, 
implantation and human fetal development, lung tissue and lung cancer, spermatogenesis, 
tumor invasion and viral infections like HIV-1 (Huppertz et al., 1998; Tanney et al., 
1998; Bord et al., 1999; Kanwar et al., 1999; Furuya et al., 2000; Vliagoftis et al., 2000; 
Ghorpade et al., 2001; Marchenko et al., 2001; Bischof et al., 2002; Schutz et al., 2002; 
Hunter and Spector, 2003; Baumgart et al., 2002; Buchman-Shaked et al., 2002). 
 With few exceptions, all MMPs described to date share conserved structural 
domains, including an N-terminal signal peptide, a propeptide region, a catalytic domain 
that contains the Zn2+ binding site, fibronectin repeats, a short hinge region, and C-
terminal hemopexin-like repeats (Becker et al., 1995; Bode et al., 1993; Hayashita-Kinoh 
et al., 2001; Sekine-Aizawa et al., 2001). MMPs differ mostly in their content of 
hemopexin-like and fibronectin repeats, with MMP-7 lacking all repeats and MMP-9 
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having the most (Figure 2.6) (Dhanaraj et al., 1996; Van Wart and Birkedal-Hansen, 
1990).  
 The signal peptide is a hydrophobic region with about 25 residues. This sequence 
targets the enzyme for secretion and is cleaved before activation. Between the signal 
peptide and the catalytic domain is a propeptide region. The propeptide forms 3 α-helices 
that contain about 80 residues and a highly conserved “Cystein switch” sequence 
PRCGVPD. Removal of the cystein residue activates the enzymes (Springman et al., 
1990; Vallee and Auld, 1990). The attachment of the propeptide region is essential in 
keeping the enzyme in an inactive state (Fisher et al., 2002).  The importance of the 
propeptide region to maintaining latency was determined by mutational studies for 
several MMPs (Murphy et al., 1999). The presence of 20 residues at the C- and N-termini 
proved crucial to the function of the propeptide; enzymatic or mutational removal of 
these sequences cause autoactivation of the enzyme (Freimark et al., 1994). The integrity 
of the propeptide region is also essential in binding tissue inhibitors of MMPs (TIMP) 
and the subsequent activation of MMPs (Pavlaki et al., 2002; Cao et al., 1998). 
 The catalytic domain is highly conserved among MMPs and contains the zinc-
binding sequence HEXGHXXGXXHS (Bode et al., 1994; Willenbrock et al., 1995). Of 
special importance are the histidines in this sequence because their disturbance by point 
mutations inactivates the catalytic domain (Windsor et al., 1994). A second Zn2+ is found 
in some MMPs but its importance is uncertain at this point. Downstream from the 
catalytic Zn2+ is a Ca2+ molecule that binds flanking His and Asp and is thought to help 
stabilize the structure (Bode et al., 1994; Willenbrock et al., 1995). The catalytic domain 
of gelatinases (MMP-2 and MMP-9) contains 3 tandem fibronectin inserts. These repeats 
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fold into double stranded antiparallel β-sheets (Clark and Cawston, 1989; Lowry et al., 
1992; Overall, 2002) and are thought to allow cooperative binding to substrates (Banyai 
et al., 1994).  
 
Figure 2.6 Structural domains of gelatinases. MMP-2 and MMP-9 are among the largest 
MMPs. They contain a signal peptide (A), a pro-domain (B), a catalytic domain (C), 
Fibronectin-repeats (D), a linker domain (E), and hemopexin-repeats (F). Other MMPs 
may lack the fibronectin-repeats and the hemopexin-repeats, while membrane-tethered 
MMPs have an additional hydrophobic domain (G).  
 
 Following the catalytic domain is a hinge region of variable length that connects 
to the C-terminal hemopexin repeats. The structure of the hemopexin domain was 
resolved by X-ray crystallography and is arranged like a four-blade propeller structure 
with 4 β-sheets (Li et al., 1995; Libson et al., 1995). This domain allows the binding to 
substrates like collagen I and II, TIMPs, and heparin (Allan et al., 1991; Crabbe et al., 











tethered MMPs, e.g. MT1-MMP, and allows the enzyme to attach to the plasma 
membrane (Okumura et al., 1997; Sato et al., 1996). 
From expression to activation, MMPs are tightly regulated to prevent deleterious effects. 
Several signal transduction cascades have been implicated in activating MMP gene 
expression including the ERK-MAP kinase, PI-3 kinase, PKC, and p38 pathways (Wang 
et al., 2002; Hussain et al., 2002; White et al., 2000b). Mounting evidence suggests that 
these pathways induce homo- and heterodimerization of c-fos and c-jun, members of the 
proto-oncogene family, which form the intranuclear transcription activator protein AP1 
(Illman et al., 2001; Sato et al., 2002). Binding sites for AP1 are found in the promoter 
sequence of most MMPs. Moreover, most MMPs have binding sites for other nuclear 
factors like NFκB, Smad, and Ets (Hall et al., 2003; Eberhardt et al., 2002).  In addition 
to MMPs, tissue inhibitors of MMPs (TIMPs) seem to be regulated by the same factors. 
For example, inhibition of AP1 binding by specific inhibitors suppresses the expression 
of MMP-1 and MMP-9 and increases the expression of TIMP-1 (Sato et al., 2002).  The 
gene expression of TIMP-1 is also induced by TGF-β1 by binding AP1, while 
concomittent interaction of Smads with the AP1 binding site on the MMP-1 promotor 
region represses the later’s gene expression (Hall et al., 2003). In a mouse model for 
hydrocephalus resulting from the overexpression of TGFβ1, a recent study found 
abnormally high expression of TIMP-1 and a simultaneous decrease in the expression of 
MMP-9 (Zechel et al., 2002). Conversely, multiple cytokines could interact and increase 
the expression and activation of MMP-9. In human skin keratinocytes, for example, 
TGFβ1 and TNFα bind to TGFβ-RE (TGFβ1 response element) and NFκB binding site 
and induce increased MMP-9 expression (Han et al., 2001).  Similarly, in malignant 
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gliomas and transformed keratinocytes, TGF-β is thought to induce the expression of 
MMP-9 (Santibanez et al., 2002; Platten et al., 2001).  In human breast cancer cells, 
heuregulin-β1, a growth factor that promotes the survival of breast cancer cells, induces 
the expression of MMP-9 through the ERK-MAPK, PKC, and p38 signal transduction 
pathways. However, the downstream signaling molecules and transcription factors 
leading to the activation of MMP-9 gene expression are yet to be identified. Furthermore, 
our knowledge of the regulation of gene expression of MMPs and their inhibitors is still 
in its early stages. 
 
Figure 2.7 Activation of MMP-2 and MMP-9’s gene expression. Several signal 
transduction pathways modulate the expression of MMP-2 and MMP-9, and the 
simultaneous release of TIMP-1 and TIMP-2. 
 
Once secreted, MMPs are activated by a variety of coumpounds including 
organomercurial, phorbolesters, SDS, reactive oxygen species like HOCl-, H2O2, ONOO-, 
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acidic pH, and other proteinases (Birkedal-Hansen and Taylor, 1982; Okada et al., 1992; 
Owens et al., 1997; Saari et al., 1990; Sopata and Wize, 1979). The activation step 
invariably involves the cleavage of the Zn2+--Cys bond, which makes the catalytic 
domain free to interact with substrates (Springman et al., 1990). MMPs are activated on 
the cell surface by membrane tethered MMPs, like MT1-MMP, by furin and plasmin, and 
by stepwise activation of other MMPs (Fillmore et al., 2001; Gveric et al., 2001; 
Makowski and Ramsby, 1998; Murphy et al., 1999; Nagase, 1997). For example, pro-
MMP-2 is activated on the cell surface by MMP-1, plasmin, and MT1-MMP.  The tissue 
inhibitor TIMP-2 binds pro-MMP-2 and presents it to MT1-MMP (Maquoi et al., 2000). 
This reaction is dependent on stochiometric concentrations of TIMP-2. Furin and plasmin 
also activate MT1-MMP (Monea et al., 2002; Sato et al., 1996), which cleaves the 
prodomain of pro-MMP-2. A similar process for the activation of pro-MMP-2 is 
mediated by integrin α(v)β(3), which binds pro-MMP-2 and presents it to TIMP-2 and 
MT1-MMP (Hofmann et al., 2000a; Hofmann et al., 2000b). After the activation of 
MMP-2, the MT1-MMP/TIMP-2 complex is quickly internalized and degraded inside 
lysosomes and endosomes (Jiang et al., 2001).  
Pro-MMP-9 is activated by trypsin, plasmin, cathepsin G, and chymotrypsin 
(Morodomi et al., 1992). Other MMPs, like MMP-1 (Sang et al., 1995), MMP-2 
(Fridman et al., 1995), MMP-3 (Goldberg et al., 1992), MMP-7 (Imai et al., 1995), 
MMP-10 (Nakamura et al., 1998), and MMP-13 (Knauper et al., 1997) cleave the 
prodomain of MMP-9 and generate an ~82 kDa active zymogen. MMP-9 autolysis can 
also occur in vivo and results in smaller 80 and 67 kDa active zymogens (Fillmore et al., 
2001; Fridman et al., 1995; Makowski and Ramsby, 1998; Murphy et al., 1999; Nagase, 
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1997). The generation of smaller fragments eventually deactivates the enzyme. 
Activation of pro-MMP-9 proceeds in a stepwise fashion through other MMPs (Ogata et 
al., 1992) and requires the dissociation of TIMP-1 – a necessary step for activation (Itoh 
and Nagase, 1995).  The stepwise mode of activation allows the formation of active 
intermediates and a greater control over the degradation of ECM molecules (Suzuki et al., 
1995). 
 Abnormal activation or secretion of MMPs is invariably associated with CNS 
pathologies. The functions of MMP-9, MMP-1, and MMP-3 have been shown to be 
disturbed in human brains affected with Alzheimer’s disease (AD). A study on 
postmortem tissue from Alzheimer’s patients, found MMP-9 in pyramidal neurons in the 
hippocampus, but not in granule neurons and glia (Backstrom et al., 1996). Active MMP-
9 can degrade β-amyloid proteins in vitro, but accumulates in a latent form around β-
amyloid plaques in tissue collected from Alzheimer’s patients. A similar observation was 
made in canine brains with β-amyloid plaques (Lim et al., 1997), which supports the 
proposition that accumulation of β-amyloid proteins is partly due to insufficient 
activation of MMP-9. A recent study investigating the distribution of MMP-9 and uPA 
(urokinase plaminogen activator), an activator of pro-MMP-9, in postmortem tissue 
collected from Alzheimer’s and vascular dementia patients revealed a segregation in the 
expression pattern (Asahina et al., 2001). In Alzheimer’s tissue, MMP-9 colocalised in 
neurons, senile plaques and the vascular wall whereas uPA was found only in the 
vascular wall. On the other hand, MMP-9 and uPA were colocalized to the vascular wall 
in vascular dementia tissue. MMP-3 also has reduced expression around senile plaques 
(Yoshiyama et al., 2000). Whether MMP-3 contributes to the pathology of AD, or not, is 
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contingent on MMP-3’s ability to degrade β-amyloid proteins, which is not known at the 
present time. In contrast to MMP-9, MMP-1 expression in AD tissue is elevated 
compared to normal tissue especially around capillaries (Leake et al., 2000), which 
suggests a role in damaging the blood-brain barrier (BBB). 
Elevated levels of MMP-9 have been reported in studies of transient focal 
ischemia (Clark et al., 1997; Fujimura et al., 1999; Planas et al., 2000). Increased 
expression of MMP-9 is first seen after 4 hrs of the ischemic insult, and is sustained for 
almost 4 days. MMP-2 expression showed a delayed response in that it increases after 4 
days of the ischemic injury (Heo et al., 1999; Planas et al., 2001). The rise in the 
expression of the active MMP-9 is believed to contribute to the damage caused to the 
blood-brain barrier and myelin membranes. Several components of the BBB, like 
laminin, and a major component of the myelin membrane, myelin basic protein, are 
degraded by MMP-9. Interestingly, MMP-9 knock-out mice show reduced damage after 
ischemic and traumatic brain injuries compared to wild type mice (Wang et al., 2000; 
Asahi et al., 2001). Administration of the broad spectrum MMP inhibitor batimastat (BB-
94) significantly decreased the damage caused by ischemic injury in wild type mice, but 
not in MMP-9 knockouts (Asahi et al., 2000). The use of BB-94 also reduces 
hemorrhagic volumes, a known complication with the administration of tPA in ischemic 
and embolic injuries (Lapchak et al., 2000; Sumii and Lo, 2002). Moreover, in clinical 
studies of stroke patients, MMP-9 plasma levels proved to be a reliable predictor of 
hemorrhagic infarcts and parenchymal hematomas (Montaner et al., 2001; Castellanos et 
al., 2003).   
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Increased MMPs’, especially MMP-9, activity and expression are also seen in 
inflammatory demyelination and malignant gliomas (Rosenberg et al., 1996; VanMeter et 
al., 2001; Yong et al., 2001).  Secretion of matrix degrading enzymes by invading 
immune cells is thought to exacerbate the damage to the ECM and myelin in MS (Sobel, 
2001; Sobel and Ahmed, 2001). Malignant and metastatic brain tumors invariably show 
increased expression of MMPs, which are believed to facilitate tumorogenic invasion and 
subsequent vascularization (Fillmore et al., 2001; Sameshima et al., 2000; Friedberg et 
al., 1998). Therapies based on MMP inhibition are under development but have to 
overcome the problems that plagued early therapies for stroke, arthritis, MS and cancer 
(Marder and Greenwald, 2003; Scappaticci, 2003; Fingleton, 2003; Zheng et al., 2003). 
One of the hurdles is the redundancy of MMPs and their wide spectrum of substrates and 
functions. A successful therapeutic approach minimizes damage cause by overexpression 
of certain MMPs, like gelatinases, without interfering with the homeostatic function of 
other MMPs. Significant advances have been made in designing specific inhibitors or 
“suicide substrates” that exhibit high affinity and specificity (Brown et al., 2000; Kleifeld 
et al., 2001). A better understanding of the mechanism of action of MMPs and their 
distribution is of utmost importance in order to design therapies that are more effective. 
 41
Chapter Three: Expression of MMP-2 and MMP-9 and their 






Matrix metalloproteinases 2 and 9 belong to the metalloendopeptidase family and 
are known to catalyze the degradation of ECM proteins including collagens, 
proteoglycans, fibronectin, and elastin (Chandler et al., 1997; Huppertz et al., 1998). 
Excess MMP production and activation is thought to be a key feature of several CNS 
pathologies. For example, remodeling of dendritic trees in the hippocampus is 
accompanied by an increased expression of gelatinases in a model of temporal lobe 
epilepsy (Szklarczyk et al., 2002; Zhang et al., 1998). MMP-9 has also been shown to be 
involved in the pathogenesis of Alzheimer’s disease (Asahina et al., 2001; Backstrom et 
al., 1996; Lim et al., 1997), ischemic injuries (Fujimura et al., 1999; Planas et al., 2001) 
and Multiple Sclerosis (Lee et al., 1999; Yushchenko et al., 2000). Accumulating 
evidence suggests that MMP-2 and MMP-9 are involved in normal developmental 
processes as the differentiation of neurons and glia (Agapova et al., 2001; Frolichsthal-
Schoeller et al., 1999), migration, and process extension by oligodendrocytes during 
development (Oh et al., 1999; Uhm et al., 1998; Vu and Werb, 2000). In the peripheral 
nervous system, neurite extension over Schwann cell basal lamina is thought to be 
facilitated by MMP-2 and MMP-9 (Ferguson and Muir, 2000). MMP-2 and MMP-9 have 
been shown to be expressed in the developing cerebellum (Vaillant et al., 1999). The 
expression of MMP-2 and MMP-9 coincided with the formation of the internal granule 
layer and the maturation of neurons and glia but the nature of their contribution is not 
understood.  
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 During the first three postnatal weeks, the cerebellar cortex of the rat is the stage 
for major developmental changes. The postnatal histogenesis of the cerebellar cortex has 
been described by Obersteiner (1883), Cajal (1911), Addison (1911), Mugnaini and 
Forstronen (1967), and several others. Progenitors of granule cells proliferate rapidly in 
the EGL between P3 and P9 and start their migration towards the internal granule layer 
by P6. Proliferating granule neurons maintain their contact with the basal lamina 
(Hausmann and Sievers, 1985). Migrating neurons extend parallel fibers that make 
synaptic contact with Purkinje dendrites. Granule cells have to pass through an already 
developed molecular layer, past the Purkinje cell layer, to reach their final destination in 
the IGL. This tortuous journey is facilitated by the interactions between granule cells and 
Bergmann glial fibers (Rakic, 1971). During the same period the dendritic trees of 
Purkinje neurons grow extensively as they synapse with parallel fibers (Addison, 1911; 
Zecevic and Rakic, 1976). Purkinje cells also interact with neighboring Bergmann glial 
fibers (Riquelme et al., 2002; Seil, 2001). Between P7 and P21 in rats, Purkinje dendrites 
become increasingly ensheathed by Bergmann glial processes and membranous 
digitations (Seil, 2001; Yamada and Watanabe, 2002). These events are known to involve 
various ECM molecules including hyaluronic acid, versicans, tenascin-R, laminin, 
proteoglycans and others (Aspberg et al., 1995; Bignami et al., 1993a; Mendis et al., 
1994; Thelen et al., 2002; Tucker et al., 1994). These molecules have adhesive or 
repulsive properties that permit migration, process extension, and plasticity of neuronal 
and glial elements. Moreover, many of these extracellular proteins are substrates for 
MMP-2 and MMP-9 (Chandler et al., 1997; Schutz et al., 2002).  
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 The important role of MMPs in the regulation of interaction between cells and the 
ECM enticed us to test the hypothesis that MMP-2 and MMP-9 contribute to postnatal 
cerebellar histogenesis. To better understand the developmental pattern of expression and 
the distribution of gelatinases, we performed realtime quantitative RT-PCR, in situ 
zymographic analysis, and immunohistochemistry on cerebellar tissue from pups at the 
postnatal age of 3 until P25. We investigated the contribution of these gelatinases to the 
developmental events that shape the cerebellar cortex by determining the effect of a 
specific gelatinase inhibitor on MMP-2 and MMP-9’s activity in cerebellar organotypic 
slice culture.  
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Materials and Methods 
 
Animal surgeries. We used four Sprague Dawley rat pups from the postnatal age 
of 3 (P3), P6, P9, P12, P15, P18, P21 and P25 for each experiment. Animals were housed 
and bred in an ACUC-accredited animal facility at West Virginia University Health 
Sciences Center. All animal protocols complied with the Society for Neuroscience 
guidelines for animal care and use. For the immunohistochemistry experiments, animals 
were anesthetized with sodium pentobarbitol (150 mg/kg body weight) then perfused 
intracardially with 4% paraformaldehyde. Brains were dissected and post-fixed in the 
same solution for 12 hrs at 4°C, cryprotected in 30% sucrose solution for 3 additional 
days, then embedded in O.C.T. compound (Optimum Cutting Temperature; Cat.# 25608-
930, VWR, Westchester, PA) and frozen on powdered dry ice. For the remaining 
procedures, brains were dissected and immediately frozen in liquid nitrogen. Tissue 
collected was stored at -80°C until further processing. 
Real-time Quantitative PCR. The cerebellum was dissected under a dissecting 
scope and immediately frozen in liquid nitrogen. For comparision purposes, cortical 
tissue from the cerebrum was dissected from the same animals by making a shallow 
tangential cut through the sagittal plane. Total RNA was extracted using TRIZOL reagent 
according to the protocol provided by the manufacturer (Life Technologies, Grand Island, 
NY). The solution was then treated with DNAse I (Ambion Inc., Austin, TX) for 30 
minutes at 37°C. DNAse I was inactivated and removed from the reaction with the 
addition of DNAse inactivation reagent (Ambion). RNA concentration was determined 
by spectrophotometric analysis at A260 and A280 using a DU 640 Spectrophotometer 
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(Beckman Coulter Inc., Fullerton, CA). Oligonucleotide primers and Taqman probes for 
rat MMPs were designed using Primer Express Software (Perkin-Elmer, Boston, MA) 
and were synthesized by Perkin-Elmer. Primer and probe sequences (5'-3') were as 
follows: MMP-2 forward primer, CCCATGAAGCCTTGTTTACCAT; MMP-2 reverse 
primer, CTGGAAGCGGAACGGAAA; MMP-2 probe, 6FAM-CAATGCTGATGGAC 
AGCCCTGCA-TAMRA. MMP-9 forward primer, CGTGGCCTACGTGACCTATGA; 
MMP-9 reverse primer, GCACCGCTGAAGCAAAAGA; MMP-9 probe, 6FAM-
CTCCTGCAGTGCCCTTGAACTAAGGCT-TAMRA; Primers and probes for rat 18S 
were purchased from Perkin-Elmer. Real-Time quantitative TaqMan PCR analysis was 
used to determine the relative levels of MMP-2 and MMP-9 mRNA. RT-PCR and 
TaqMan PCR were performed according to the manufacturer's instructions (PE 
Biosystems, TaqMan Gold RT-PCR protocol and TaqMan Universal PCR Master Mix). 
Sequence-specific amplification was detected with an increase fluorescence signal of the 
reporter dye FAM during the amplification cycle. Amplification of the gene for rat 18S 
was performed in the same reaction on all samples tested as an internal control for 
variations in RNA amounts. Levels of the different mRNAs were subsequently 
normalized to 18S mRNA levels, and were represented as fold difference of various 
postnatal ages against age of day 3. 
Culture of cerebellar granule neurons. Dissociated cerebellar cell culture were 
used to ascertain the presence of and determine the probable source of gelatinases in the 
cerebellum. Cerebellar granule neurons and glial cells were isolated from P4 rat 
cerebella, cultured, and then assayed for gelatinase activity. Primary cultures of CGNs 
and glial cells were generated as previously described (Luo et al., 2001; Li et al., 2001). 
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Briefly, the cerebellum was dissected out and quickly placed in a 2 ml conical tube filled 
with 1H buffer (50 ml EBSS, 0.125 g Glucose, 0.15 g BSA, 0.5 ml of 3.82% 
MgSO4,7H2O). All tissue was finely chopped with a razor blade on a glass slide and 
moved to a 50 ml conical tube full of solution A (0.1 ml of 25 mg/ml trypsin, 9.9 ml 1H 
buffer). After vigorous shaking, the tube was placed in the incubator/shaker at 37°C for 
15 min to allow ample time for trypsinization. Next, solution C was added (9.78 ml 1H, 
160 µl of 4 mg/ml trypsin inhibitor, 30 µl of 200 U/ml DNAse and 30 µl of 3.82% 
MgSO4, 7H2O) and centrifuged the mixture at 1000 rpm for 5 minutes. After removing 
the supernatant, trypsin inhibitors (buffer B: 8.6 ml 1H, 1 ml of 4 mg/ml trypsin inhibitor, 
0.2 ml of 200 U/ml DNAse, 0.2 ml of 3.82% MgSO4, 7H2O) was added to the tube, 
swirled the mixture thoroughly and left to settle for 5 min. The supernatant was 
transferred to a 15 ml tube, combined gently with solution D (9.8 ml 1 H, 400 mg BSA, 
and 0.2 ml 3.82% MgSO4, 7H2O), and the mixture was spun down for 5 min at 2000 rpm. 
The solution was discarded again and the pellet, which contained CGNs, was suspended 
in culture media and plated over PDL-coated culture dishes. For glial culture, the pellet 
was transferred to a flat culture bottle with 10 ml DMEM and incubated for the same 
period. After 48 hrs, cultured Cells and and their conditioned media were collected in 
separate tubes and processed for gelatinase assay. 
Organotypic slice culture. Organotypic slice cultures were prepared from 
postnatal day 5 cerebella. The animals were numbed on ice for several minutes, and then 
the cerebellum was rapidly extracted and immersed in oxygenated-ACSF (artificial 
cerebrospinal fluid). Cerebella were sectioned at 500 µm thickness in the parasagital 
plane with a Vibraslicer (WPI, Sarasota, FL). Slices were cultured on collagen-coated 
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Nucleopore membrane (Millipore, Bedford, MA) at the interface between air and culture 
medium according to the method of Kunimoto and Suzuki (1997) and Tanaka et al. 
(1994), with minor modifications (Jin et al., 2001). Two slices were placed on every 
membrane, and four membranes in each sterile six-well culture plate, each over 1 ml of 
culture media. Culture media was changed every two days and 24 hrs before each 
harvest. The slices were incubated at 37ºC and 5% CO2 atmosphere.  
Gelatinase Assay. Zymographic analysis was performed on proteins extracted 
from freshly frozen tissue, cerebellar granule neuronal cultures, mixed glial cultures, and 
conditioned media from cerebellar organotypic slice cultures. Cerebella were dissected 
out from P3 to P25 rat pups and quickly frozen in liquid nitrogen. Proteins were extracted 
as described earlier (Li et al., 2001). Samples were collected from three animals at each 
time point and three cell culture replications, and gelatinase assays were repeated 5 times 
for each sample. In the case of in vitro preparations, culture media containing secreted 
proteins were collected in addition to the cell lysates. The concentration of proteins in 
extracts was determined by a Lowry assay then equal amounts of protein were loaded in 
the electrophoretic gel. The gel was prepared with substrate (1 mg/ml gelatin) 
copolymerized with 10% SDS-polyacrylamide. Equal volumes (25 µl) of the proteins 
were prepared with RIPA buffer and 4x non-reducing sample buffer. All samples were 
kept on ice during the whole procedure until loaded in the gel to minimize denaturation 
of proteins and enzymes. After 3 hrs of electrophoresis, gels were washed with 2.5% 
Triton X-100 for 30 min at room temperature, then with a rinse buffer (50mM Tris-HCL 
pH7.4, 0.1M NaCl, 2.5% Triton-100) for an additional 60 min, followed by an overnight 
incubation at 37°C in reaction buffer (50mM Tris-HCL pH7.4, 10mM CaCl2). Gels were 
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then stained with a solution of Coomassie blue (0.5% Coomassie blue R in 45% MeOH, 
10% acetic acid) for 60 min, then de-stained in a solution of 10% MeOH and 10% acetic 
acid until the digested bands are clear. To further ascertain equal loading in gels, we cut 
the top 2 cm from each gel and stained it with Coomassie blue for 5 min. Gels were 
photographed on a trans-illuminator using a Sony CCD Camera and digitally captured 
and processed using the Eagle Sight® Software (Stratagene). Densitometric 
quantification of the digested bands was performed on FluorChem SA (Alpha Innotech 
Corp., San Leandro, CA) and graphed using MS Excel (Microsoft Corp., Seattle, WA). 
Densitometry measurements were collected after calibration for background intensity and 
loading controls, and then data were analyzed using SigmaSTAT statistical software 
(SPSS Inc., Chicago, IL; see statistical analysis for more details). 
Reverse Zymography. The levels of gelatinase inhibitors in tissue affect the 
availability and effectiveness of MMP-2 and MMP-9 in digesting ECM molecules. 
Reverse zymographic analysis was performed on protein extracts to monitor for the 
presence of gelatinase inhibitors. Briefly, the experiment proceeds in a similar fashion to 
the gelatinase assay, except that a 12% SDS-polyacrylamide gel (containing 1 mg/ml 
Gelatin) was prepared with a mixture of pro-MMP-2 and pro-MMP-9, which were 
activated with APMA (p-Aminophenylmercuric Acetate) following manufacturer 
instructions (Cat.# 444213, 444231, 164610; Calbiochem, San Diego, CA). This 
procedure uncovered bands of gelatinase inhibitors, TIMP-1 and TIMP-2, where the 
added enzyme did not digest the gelatin. Loading controls and densitometry were 
preformed as described for the gelatinase assay. 
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In situ zymography. Brains were embedded and frozen in O.C.T. compound 
directly after the dissection and without fixation. Specimens were sectioned using a 
cryostat at 20 µm thickness, then stored at -20°C until stained. All slides were incubated 
in a solution containing 0.05 M Tris-HCl, 0.15 M NaCl, 5 mM CaCl2, 0.2 mM NaN3 (pH 
7.6) and 40 µg/ml of FITC-labeled gelatin (Molecular Probes, Eugene, OR), on a shaker 
at 37°C for 24 hrs. Slides were coverslipped with Vectashield mounting media after 
blotting excess fluids, and without any rinses. This technique allowed endogenous 
gelatinases to digest the gelatin producing a fluorescent reaction product, which was 
detected using conventional fluorescent microscopy as in Oh et al (1999). We pre-
incubated control sections in 20 mM EDTA for 1hr, or 4% formaldehyde for 10 min, to 
determine the specificity of the enzymatic activity (Mook et al., 2003). We detected the 
fluorescence with excitation at 460-500 nm and emission at 512-542. Slides were imaged 
on an Olympus AX70 microscope (Olympus America Inc., Melville, NY) equipped with 
a Spot 2e digital camera (Diagnostic Inst. Inc., Sterling Heights, MI). Camera settings, 
including optical gain, exposure, and brightness control were the same for captured 
images. Pictures were imported directly into Adobe Photoshop 5.5 (Adobe Systems Inc., 
San Jose, CA) for cropping and labeling.   
Immunohistochemistry. Brains were sectioned parasagitally on a LEICA 
cryostat at 12 µm final thickness and collected on superfrost plus slides (Fisher); they 
were then stored at -20°C until processing. Sections representing all experimental ages 
and controls were stained at the same time to minimize variability. Slides were rinsed and 
cleared in 25% ethanol solution for 5 min to remove excess tissue freezing compound. 
This step was followed by 5 min rinse in ddH2O and 10 min in PBS containing 0.1% 
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Triton-X 100. Slides were incubated in primary antibodies against MMP-2, MMP-9 (all 
goat-anti-rat; sc-6838, sc-6840; Santa Cruz Biotech. Inc., Santa Cruz, CA) diluted 1:1000 
in PBS with 1% normal horse serum (Wagner et al., 2003). Primary antibodies against 
GFAP and Calbindin (mouse anti-rat; Sigma G3893 and C9848) were prepared at a final 
dilution of 1:1000 and 1:3000 respectively. After 24 hours at 4°C, slides were placed at 
room temperature for 15 min to equilibrate, and rinsed 3 times in PBS for a total of 30 
min. Slides were then incubated in FITC-labeled anti goat secondary antibody or FITC-
labeled anti-mouse (1:200 in PBS; Zymed Laboratories Inc, South San Francisco, CA) 
for 2 hrs at room temperature. The nucleic acid stain TOTO-3 iodide (T-3604, Molecular 
Probes, Eugene, OR) was diluted with the secondary antibody at a final concentration of 
1 µg/ml. After three rinses in PBS, slides were covered with Vectashield (Vector labs) 
solution and coverslipped. We processed negative control sections, by omitting the 
primary antibody, with every batch of stain. Furthermore, to test the specificity of the 
primary antibodies, we incubated sections with MMP-2 antibody preabsorbed with the 
specific blocking peptide (sc-6838p, Santa Cruz Biotech), and with MMP-9 antibody 
preabsorbed with MMP-9 blocking peptide (sc-6840p). All immunohistochemically 
prepared slides were imaged using a Zeiss LSM 510 confocal microscope (Carl Zeiss 
Imaging Inc., Thornwood, NY). The same settings for filters, pinhole size, stack size and 
resolution, were used for all captured images. All images were cropped and labeled using 
Adobe Photoshop 5.5. 
Treatment with gelatinase inhibitor. Organotypic slices were prepared from P5 
pups, as described earlier, and treated with a selective MMP-2/MMP-9 inhibitor (1.6 µM, 
3.2 µM and 6.4 µM; SB-3CT; 80512-564; VWR) or without inhibitor (Controls) diluted 
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in culture media for 24hrs, 4 days in vitro (DIV), 7DIV, and 10DIV. This gelatinase 
inhibitor functions as a substrate analogue, and binds with specificity and high affinity to 
the enzyme active site (Ki = 13.9 nM for MMP-2; Ki = 600 nM for MMP-9) (Brown et 
al., 2000; Kleifeld et al., 2001; Rosenblum et al., 2003). We collected slices after 1DIV, 
4DIV, 7DIV, and 10DIV (table 3.1).  
 
1DIV-C 1DIV-1.6 µM 1DIV-3.2 µM 1DIV-6.4 µM 
4DIV-C 4DIV-1.6 µM 4DIV-3.2 µM 4DIV-6.4 µM 
7DIV-C 7DIV-1.6 µM 7DIV-3.2 µM 7DIV-6.4 µM 
10DIV-C 10DIV-1.6 µM 10DIV-3.2 µM 10DIV-6.4 µM 
 
Table 3.1 Slice culture treatment groups. Serial slices were distributed in four treatment 
groups and incubated for 1, 4, 7 and 10 days in vitro. Slices were treated with SB-3CT at 
increasing concentrations for the entire culture period. We collected the culture media for 
gelatin zymography and the slices were sectioned for immunohistochemistry and in situ 
zymography.  
 
For each treatment group and time point, we collected the culture media, since it contains 
secreted proteins, and stored it at -80ºC until further processing with gelatin zymography. 
The slices were embedded in O.C.T. compound and frozen at -20°C between 2 glass 
slides on a flat metal block (Haydar et al., 1999). This procedure helped us maintain the 
slices flat and allowed us to section the slices thinner for immmunohistochemistry and in 
situ zymography. 
Morphometric analysis. several parameters were monitored to assess the effect 
of MMP inhibitor on the histogenesis of the cerebellar cortex in organotypic slices (n = 6 










cells in the molecular layer was counted. Measurements were taken from three lobes in 
every section. Lobes were assigned by systematic random sampling. Sampling areas 
(325.7 µm x 325.7 µm) were predefined and equivalent in all treatment groups to 
minimize variability. Three lines were drawn to define the EGL and the ML. We 
measured the thickness of the EGL as the minimum distance between tangents to the 
lines defining the EGL and counted the number of cells with migrating morphology 
(fusiform somata) in the ML (see Appendix A10 for an example).  
Statistical analysis. Parametric data were analyzed data by an ANOVA followed 
by post-hoc Tukey's t-test comparisons between groups when appropriate, using 
SigmaSTAT statistical software (SPSS Inc.). Bartlett's statistic was used to identify 




Developmental mRNA expression of MMP-2 and MMP-9 
 
The gene expression of MMP-2 and MMP-9 is modulated by a variety of factors 
expressed during development including growth factors, cytokines, and ECM molecules 
(Vu and Werb, 2000). We measured the relative mRNA expression of MMP-2 and 
MMP-9 in cerebella and tissue from cerebral corteces of rat pups from P3 to P25. As 
measured by real-time quantitative PCR MMP-2 mRNA decreased by 40% between P3 
and P6, and by an additional 20 % between P6 and P25 (Figure 3.1A). In comparision, 
MMP-2 expression in the cerebral cortex gradually deceased from P3 to P25 (Figure 
3.1B). The expression of MMP-9 in the cerebellar cortex decreased by 3-fold from P3 to 
P6 and remained constant thereafter (Figure 3.1A). In comparision, the mRNA 
expression of MMP-9 in cereberal tissue increased dramatically after postnatal day 12 
and continued to rise until postnatal day 25 (Figure 3.1B). Since tissue were dissected 
from the same animals, prepared, and analysed at the same time to reduce variability, 
then the observed changes are specific to each of theses cortical areas. 
 
Developmental changes in MMP-2 and MMP-9 activity 
  
Matrix metalloproteinases are secreted as inactive enzymes into the extracellular 
matrix (Corcoran et al., 1995). Their activation is the last step in a highly controlled 
process and is needed to start their proteolytic activity (Murphy et al., 1999; Nagase, 
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1997). It is thus important to distinguish between the levels of pro-enzyme and the 
proteolytically active enzyme. To determine the spatiotemporal levels of activation of 
MMP-2 and MMP-9 in the cerebellar cortex between P3 and P25, we performed a 
zymographic assay on protein extracts from freshly frozen tissue, on cultured cerebellar 
granule neurons (CGN) and on glial cell cultures prepared from same-age cerebella. This 
was followed by an in situ zymographic assay on freshly frozen cryostat sections. We 
were able to detect bands of pro-MMP-2 at 72 kDa and weaker bands of active MMP-2 at 
68 kDa. The gelatinase activity showed a progressive decrease in the concentration of 
pro-MMP-2 from P3 until P15 (Figure 3.2A, G). Since zymographic assays are sensitive 
enough to detect picogram amounts of gelatinases (Troeberg and Nagase, 2003), then the 
weak MMP-2 activity suggests a limited tissue-spread and a focused role for MMP-2. As 
for MMP-9’s expression, the predominant form before P12 is the active form (Figure 
3.2B, H). After P12, the latent pro-MMP-9 increased in proportion while the overall 
expression profile of MMP-9 (active and latent) started to decrease. We also measured 
the activity of the tissue inhibitors of MMPs, TIMP-1 and TIMP-2, by reverse 
zymography. We detected TIMP-2 (21 kDa), but not TIMP-1 (28 kDa), in the reverse 
zymographic assay (Figure 3.2 C, I). TIMP-2 binds to and controls the activity of MMP-
2. The activity of TIMP-2 increased between P3 and P9 and leveled afterwards.  
 To determine the source of the gelatinolytic activity in the cerebellum, we 
performed a gelatinase assay on conditioned media and cell lysate from cultured 
cerebellar granule neurons (CGN) and glial cells prepared from P4 cerebella. In culture, 
CGN showed high activity for pro-MMP-2 (72kDa), two active fragments of MMP-2 at 
68kDa and 65 kDa, as well as pro-MMP-9 (92kDa) and the active MMP-9 at 80kDa 
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(Figure 3.2E). In glial culture, we detected pro-MMP-2 and MMP-2 (68 and 65 kDa), and 
a relatively weaker band of pro-MMP-9 (Figure 3.2F).  
We performed an in situ zymography assay on frozen cerebellar slices from P3 to 
P25, which allowed us to visualize the distribution of active forms of the gelatinases. 
Even though this method is sensitive to minute amounts of the gelatinases, it does not 
offer the high resolution achieved with immunohistochemical methods. In order to detect 
developmental changes, we used the same optical settings to capture all images. Briefly, 
we took 20 µm cryostat sections from fresh-frozen brains from P3 to P25. After 24 hr 
incubation with FITC-quenched gelatin, we detected fluorescence in areas of the sections 
where active MMPs cleaved gelatin. In the cerebellum, the fluorescence was mostly 
present in the EGL, the Purkinje cell layer and the IGL (Figure 3.3). The fluorescence in 
the pial basal lamina and the EGL was more intense than in the ML and the white matter. 
From P3 to P15, the distribution of gelatinase activity changed to include more of the 
internal granule layer and not just the EGL and PCL. During the same period, we 
observed a progressive decrease in proteolytic activity limited to the cerebellar cortex. 
Gelatinase activity was still detectable in the same sections in the hippocampal formation 
at P15 (Figure 3.3A) and persisted beyond P21 (not shown). We processed control 
sections as described by Mook et al. (2003) to ascertain the specificity of the fluorescent 
signal. Briefly, we incubated sections with gelatin-DQ® (Molecular Probes) as a 
substrate after blocking the gelatinase activity with 20mM EDTA or 4% formaldehyde. 




Developmental changes in MMP-2 and MMP-9 immunoreactivity 
 
To determine the distribution of MMP-2 and MMP-9, we performed 
immunohistochemical staining on serial sections from the cerebellum. Briefly, for this 
experiment, fixed tissue was sectioned in the sagittal plane at 12 µm thickness and probed 
for MMP-2 and MMP-9 with specific antibodies, followed by FITC-tagged secondary 
and counterstained with TOTO-3 iodide, a fluorescent nucleic-acid binding dye. Sections 
were imaged using a LSM510 confocal microscope under the same optical settings (see 
methods) and optical stacks were later collapsed into one image. In cerebellar sections, 
staining with TOTO-3 was noticeably more intense in the cytoplasm of Purkinje cells 
than in their nuclei (Figure 3.4). TOTO-3 iodide binds with specificity to nucleic acids, 
nuclear DNA and cytoplasmic RNA, which may have contributed to the cytoplasmic 
staining in Purkinje neurons. This diffuse staining seems more noticeable in cells with 
higher cytoplasmic RNA content and bigger somata (Boutonnat et al., 2000; Suzuki et al., 
1997). Sections of similar age groups were also stained for Calbindin D28k, which stains 
Purkinje neurons in the cerebellum. We detected calbindin immunoreactivity in Purkinje 
cell bodies, dendritic trees, and axons (Figure 3.4). We also stained sections with anti-
GFAP antibody, which is expressed in Bergmann glia in the cerebellar cortex and 
astrocytes in the white matter (Levitt and Rakic, 1980; Dahl and Bignami, 1973). The 
immunoreactivity of GFAP increased in the first postnatal week and was stable 
afterwards. Bergmann glial endfeet stained intensly with GFAP, whereas Bergmann 
fibers stained more intensly as they approached the EGL. Immunostaining was present in 
perikarya (although less numerous in our sections) and absent in short bushy lamellate 
expansions seen in silver impregnation preparations; a comparable pattern was reported 
 58
by other authors (for details see Levitt and Rakic, 1980). Artifacts and weaker stain were 
noticeable in some speciments and might be due to the age of animals, the condition of 
the tissue, and other conditions. However, the use of GFAP and calbindin allowed us to 
compare the cellular sources of MMP-2 and MMP-9, and tentatively identify cellular 
elements. Double or triple stain for GFAP, calbindin, and MMP (-2 or -9), would have 
presented better cellular identification; however, we were unable to preserve the integrity 
of the tissue and get consistant results using this approach. 
We detected MMP-2 immunoreactivity in Purkinje somata and initial dendritic 
trunks, in radial fibers resembling Bergmann glial fibers and in the EGL (Figure 3.4 - 5). 
MMP-2 immunoreactivity was strongly reduced in Bergmann glial fibers after P12 and in 
Purkinje cells after P15. Immunoreactivity of MMP-9 staining coincided with Purkinje 
neurons and the EGL (Figure 3.4 - 6). Diffuse staining was also noticeable around the 
Purkinje dendrites, which indicates the detection of MMP-9 in the extracellular space. 
MMP-9 staining in Purkinje cells was below detection after P18. Figures 3.5 and 3.6 
show representative fields from sections treated with MMP-2 and MMP-9 antibodies at 
higher magnification. We processed negative control sections, where we omitted the 
primary antibody, with every batch of stain. To further ascertain the specificity of the 
antibodies, we incubated sections with the primary antibody pre-absorbed with the 
corresponding specific blocking peptide. Figure 3.7 shows representative control sections 
from P15 stained with MMP-9 antibody pre-absorbed with increasing dilution of MMP-9 
blocking peptide (Santa Cruz Biotech). As can be noticed, the immunoreactivity 
increased as the concentration of the blocking peptide was reduced in relation to the 
antibody from 1:10, 1:20, 1:50, and was comparable to full antibody staining when we 
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omitted the blocking peptide (0:1). Similar results were observed with MMP-2 
preabsorbed with the MMP-2 blocking peptide (not shown). 
 
Effect of specific MMP-2 and MMP-9 inhibitor on cerebellar morphology 
 
We used organotypic slice cultures from cerebella of P5 rat pups. This technique 
has proved very useful in studying the developmental mechanisms in cerebellar cortex 
without sacrificing the role of the ECM and intercellular communication (Haydar et al., 
1999). We cultured cerebellar slices for 1 day (1DIV = 1 day in vitro), 4DIV, 7DIV, and 
10 DIV as described earlier (Jin et al., 2001; Tanaka et al., 1994). At each time point, 
serial slices were divided in four groups, three of which received treatment with a 
selective MMP-2/MMP-9 inhibitor (SB-3CT) at increasing concentrations (1.6, 3.2 and 
6.4 µM) and a control group. This inhibitor was shown to bind specifically to MMP-2 
and MMP-9 in a manner similar to TIMP-1 and TIMP-2 (Kleifeld et al., 2001). At the 
end of the treatment period (24hrs, 4 days, 7 days, and 10 days) we collected and stored 
the culture media, which contains secreted enzymes, and the slices at -80ºC. We 
performed a zymographic assay on the culture media and in situ zymography on 
sectioned slices. We also sectioned and stained cerebellar slices to quantify the effect of 
inhibitor treatment on the histogenesis of the cerebellar cortex.  
We processed alternate serial sections with immunohistochemistry for MMP-2, 
MMP-9, Calbindin D28K, and GFAP, and with in situ zymography from treatment 
groups and controls. The immunoreactivity of MMP-2 and MMP-9 followed an 
expression pattern similar to that observed in vivo. Figure 3.8 (A, B, C, and D) shows 
sample sections from control slices at 7DIV immunostained for MMP-2, MMP-9, 
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Calbindin D28k and GFAP. Figure 3.8 (E and F) shows a sample from sections processed 
for in situ zymography taken from adjacent slices at 7 days in vitro. The distribution of 
the gelatinase activity in the section in (F) treated with 3.4 µM SB-3CT was reduced and 
less uniform compared to the section in (E), which was taken from the adjacent control 
slice and imaged under the same optical settings. We observed a similar pattern of 
reduced and irregular activity in other slices exposed to SB-3CT at other concentrations. 
We performed a zymographic assay on the culture media collected from inihibitor 
treated slices and controls (Figure 3.9A-F). The concentration of proteins in conditioned 
media was determined by a Lowry assay and the same amount of proteins was loaded in 
all wells (see methods). A progressive decrease in gelatinase activity, similar to the 
expression pattern detected in vivo, was measured for both MMP-2 and MMP-9 in 
control slices at all time points (Figure 3.9 A and F). Treatment with the specific inhibitor 
SB-3CT was accompanied by a progressive decrease in gelatinase activity. At 7 DIV and 
10DIV (Figure 3.9 B, E, F), the activity of MMP-2 was still detectable, whereas the 
activity of MMP-9 was drastically reduced. To acetain equal loading in the gels, we cut 
and stained the top 2 cm of each gel, after electrophoresis and without incubation, with 
coomassie blue for 5 min.   
To assess the effect of MMP-2/MMP9 inhibitor treatment on the development of 
the cerebellum, we measured the thickness of the EGL before and after inhibitor 
treatment (Table 3.2; Figure 3.10 A). The EGL is composed of a dense population of 
cells between the pial basal lamina and the molecular layer, which provides a convenient 
method to delineate its outer and inner boundaries. This method has been successfully 
used to assess the effect of exogenous compounds on the proliferative activity of 
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progenitors and migratory activity of immature postmitotic neurons (Ohmori et al., 1999; 
Doughty et al., 1998). To minimize error and bias, we chose the counting fields by 
systematic random sampling. All fields were equivalent in dimension (325.7 µm x 325.7 
µm) at 20x magnification regardless of age and treatment conditions. Treatment with 
inhibitor caused a significant dose-dependent increase in the thickness of the EGL 
compared to controls at 1DIV 1.6 µM, 3.2 µM, 6.4 µM (F(3,53) = 38.42; all p<0.001), and 
4DIV 3.2 µM (F(3, 53) = 11.84; p<0.01) and 6.4 µM (p<0.001). At 7DIV, the thickness of 
EGL was significantly thicker in 7DIV 1.6 µM, 7DIV 3.2 µM, and 7DIV 6.4 µM (F(3, 53) 
= 112.5; all p<0.001). At 10 DIV, slices treated with 1.6 µM and 3.2 µM inhibitor had 
significantly thicker EGL (F(3,53) = 368.0; p<0.001); while slices treated with 6.4 µM 















Table 3.2 Percent change in the thickness of EGL after treatment with SB-3CT. 
Comparision of the average percent change in the thickness of the EGL in treated slices 










-30.9% (± 0.35) +11% (± 0.32) +17.4% (± 0.36) 10DIV 
+22.8% (± 0.61)+42.3% (± 1.31) +58.6% (± 0.73) 7DIV 
+24.2% (± 1.61)+17.1% (± 1.58) +8.2% (± 2.37) 4DIV 
+30.4% (± 0.67)+26.2% (± 0.98) +14.1% (± 1.66) 1DIV 
6.4 µM Inhibitor 
(±SEM) 
3.2 µM Inhibitor 
(±SEM) 
1.6 µM Inhibitor 
(±SEM)  
Percent difference compared to control slices
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We also counted the number of fusiform-shaped cells, presumed granule cells, in the 
molecular layer (Table 3.3; Figure 3.10 B). We limited our counting to cells with round 
or fusiform nuclei smaller than 7.5 µm in diameter to exclude the bigger nuclei of other 
interneurons. The number of fusiform-shaped granule cells in the molecular layer was 
also affected by the inhibitor treatment. There was a dose-dependent decrease in the 














Table 3.3 Percent change in the number of migrating cells in the ML after treatment with 
SB-3CT. Comparision of the average percent change in the number of migrating granule 
neurons in the ML in treated slices compared to in-group controls. 
 
The effect was significant in 1DIV 3.2 µM (F(3,53) = 7.348; p<0.05), 4DIV 1.6 µM (F(3, 53) 
= 38.31; p<0.01), and highly significant (p<0.001) in 1DIV 6.4 µM, 4DIV 3.2 µM, 4DIV 
6.4 µM, 7DIV 1.6 µM (F(3, 53) = 65.82), 7DIV 3.2 µM, 7DIV 6.4 µM, 10 DIV 1.6 µM 
(F(3, 53) = 129.8), 10 DIV 3.2 µM, and 10DIV 6.4 µM respectively. Blocking the activity 
of gelatinases caused an increase in the thickness of the EGL and a decrease in the 
number of granule neurons in the ML. These results are indicative of either altered 
-72.1% (± 0.83) -48.7% (± 1.14) -28.8% (± 1.06) 10DIV
-62.1% (± 0.96) -28.5% (± 1.47) -19.9% (± 1.68) 7DIV 
-46.6% (± 1.08) -27.3% (± 1.52) -17.4% (± 2.56) 4DIV 
-22.3% (± 1.71) -16.4% (± 1.92) -2.5% (± 1.99) 1DIV 
6.4 µM Inhibitor 
(±SEM) 













proliferation of progenitor cells in the EGL, altered initiation of migration of immature 




We examined the expression, activity, and contribution of the matrix 
metalloproteinases 2 and 9 in the postnatal rat cerebellar cortex using a variety of 
experimental approaches. Temporal patterns of expression and activity pointed to the 
involvement of MMP-2 and MMP-9 in the cellular events that shape the cerebellar 
cortex. During the first two postnatal weeks, granule neurons complete their migration 
from the external granule layer to the internal granule layer. Before the end of the second 
postnatal week, the rate of granule cell migration significantly decreases while other 
cerebellar interneurons, stellate, Golgi, and basket cells complete their maturation 
(Altman, 1972a; Altman, 1972b). This period is also important for the maturation of 
Bergmann glial fibers and the growth of Purkinje cell dendritic trees (Seil, 2001; Zecevic 
and Rakic, 1976).  
 
Developmental mRNA expression of MMP-2 and MMP-9 
 
 
We determined the level of mRNA expression in the cerebellar cortex by realtime 
quantitative RT-PCR (Figure 3.1). The level of MMP-2 mRNA expression in the 
cerebellar cortex decreased sharply between P3 and P6 and more gradually between P6 
and P25. In the cereberal cortex during the same period, MMP-2 mRNA progressively 
declined from P3 until P25. The transcript levels of MMP-9 remained unchanged 
between P6 and P25 after an initial decrease from P3 to P6. In comparision, the level of 
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MMP-9 mRNA expression increased significantly in cerebral tissue from P6 to P25. 
During this period in the rat neocortex, dendritic trees of cortical neurons are expanding 
and axons are beginning to acquire a myeling sheath. Both, dendritic remodeling and 
process extension of oligodendrocytes, are known to involve gelatinases (Oh et al., 1999; 
Szklarczyk et al., 2002; Uhm et al., 1998). The mRNA expression for MMP-9 was 
previously studied by Vaillant et al. (1999). They observed MMP-9 mRNA in the 
cerebellum at P10 and P15 by in situ hybridization; however, they did not detect MMP-
2’s mRNA. Their observations in the cerebellum at P10 and P15 are in accordance with 
our data, except that we detected a preceding decrease between P3 and P6. The decline in 
MMP-9’s mRNA may have an impact on the level of pro-MMP-9 and, subsequently, the 
active MMP-9 available for the degradation of ECM proteins. Other regulatory 
mechanisms may be at play as well, especially the possibility that MMP-9 is controlled 
post-transcriptionally or post-translationally. Modulation and expression of the transcript 
of gelatinases, MMP-2 and MMP-9, can occur on a localized level, within a cell type or 
cell layer, and not at the organ level. Studies on gliomas, astrocytomas, and other 
metastatic brain tumors give ample support for this proposition (Raithatha et al., 2000; 
Vince et al., 1999; Lampert et al., 1998). In these studies, gelatinase transcripts were 
detectable only within cancerous tissue and not in the surrounding normal tissue. 
Evidence from these studies and other work on lung, liver, skin, and ovarian cancers links 
this expression to migration, invasiveness, and to neovascularization (Gokaslan et al., 
1998; Platten et al., 2001; Furuya et al., 2000; Hah and Lee, 2003; Rooprai and 
McCormick, 1997).  
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Developmental changes in MMP-2 and MMP-9 activity 
 
 
The physiological roles of MMP-2 and MMP-9 are dependent on the availability 
of the latent enzymes and their subsequent activation (Vu and Werb, 2000). We 
examined the gelatinase activity of MMP-2 and MMP-9 in the cerebellar cortex from rat 
pups and found that the activity gradually decreases in the first 25 postnatal days (Figure 
3.2 A-D, G-I). The gelatinase activity of MMP-2 decreased progressively from P3 until 
P18 and was constant afterwards. Vaillant et al. (1999) reported gelatinase assays for 
only three time points (P10, P15 and adult) with somewhat different results. Even though 
Vaillant and colleagues reported a constant level of MMP-2 throughout development, 
close inspection of their results suggest a modest decrease between P10 and P15; 
however, no quantitative data was reported to clarify this discrepancy. In the current 
study, we studied eight time points covering the period from birth to P25. Furthermore, to 
address differences with published results (Vaillant et al. 1999), we performed 
densitometric analysis on zymographic gels (n=5 per time point), which supported our 
observations (Figure 3.2 A, G). MMP-2 activity gradually decreased between P3 and P18 
and stabilized afterwards.  
During the same period, reverse zymography assays showed constitutive activity 
for TIMP-2 (21 kDa) between P9 and P25, after an initial slow increase between P3 and 
P9 (p<0.05; Figure 3.2 C, I). This suggests that the activity of MMP-2 is being controlled 
at yet another level. In fact, TIMP-2 binds and inhibits MMP-2 (Nagase, 1997), and 
functions as an adaptor protein between pro-MMP-2 and its activators, MT-MMPs. High 
levels of TIMP-2 saturate all the binding sites on MT-MMPs (membrane tethered MMPs) 
and block the activation of MMP-2, whereas low levels favor binding and activation 
 67
(Murphy et al., 1999). The availability of TIMP-2, which may limit the activation of pro-
MMP-2, combined with a progressive decrease in MMP-2’s gelatinase activity suggests a 
more significant developmental role for MMP-2 in the first postnatal week than in the 
second and third postnatal weeks.  
As for MMP-9 (Figure 3.2 B, H), the active form was predominant between P3 
and P12. The proportion of the latent form increased on and after P12, however, the total 
MMP-9 activity (latent and active) gradually decreased after P18. These data suggest a 
switch in the available form of MMP-9; the active enzyme was predominant until P9, 
while the latent form increased afterwards. Vaillant et al. (1999) reported a parallel 
pattern, with MMP-9’s activity strong at P10 but hardly noticeable at P15 and in adults. 
Quantitative analysis of our gels by densitometry supports our qualitative observations 
(p<0.05; Figure 3.2 H). In reverse zymographic assays, we did not detect TIMP-1 (28 
kDa), which normally binds to and inhibits MMP-9. The absence of the inhibitor TIMP-1 
and the availability of the catalytically active form of MMP-9 suggest the involvement of 
MMP-9 in the biochemical and cellular events between P3 and P15, and a declining role 
afterwards. The activity of these enzymes persists longer than their RNA message, which 
supports the idea of translational, post-translational or post-transcriptional regulation of 
the activity and expression of MMP-2 and MMP-9.    
To determine the potential source of MMP-2 and MMP-9 activity in the 
developing cerebellum, we isolated and cultured CGNs from P4 cerebella. After 48 hrs in 
culture, we performed a zymographic analysis on the conditioned media, which contained 
secreted proteins (Figure 3.2 E). We also performed a zymographic analysis on 
conditioned media from glial cultures isolated and cultured from same age cerebella. 
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Both CGNs and glial cells in vitro expressed pro-MMP-2 (72 kDa) and MMP-2 (68 kDa 
and 65 kDa). On the other hand, pro-MMP-9 and MMP-9 expression was more 
prominent in CGNs than glial cells. This suggests that granule neurons and glial cells are 
a potential source of gelatinases in the developing cerebellar cortex, with CGNs 
expressing both MMP-2 and MMP-9. 
We used an in situ zymography assay to determine the spatial distribution of 
active gelatinases (Figure 3.3). This technique has been successfully used to study the 
distribution pattern and changes of gelatinases in the developing and adult nervous 
system (Oh et al., 1999; Szklarczyk et al., 2002). In cerebellar sections, the distribution of 
gelatinase activity in the cerebellar cortex gradually increased between P3 and P12. 
Initially the activity was present in the EGL and basal lamina. Between P9 and P12, the 
distribution of gelatinase activity progressively increased to include the Purkinje cell 
layer and the IGL. By P15, however, the gelatinase activity decreased to a minimal level 
in all layers of the cerebellar cortex. In contrast, gelatinase activity in the hippocampal 
formation was still detectable at P15 in the same section (Figure 3.3), demonstrating that 
the decrease in activity was localized to the cerebellum. This decrease in activity from 
P12 to P15, as detected with in situ zymography, mirrors the pattern observed in 
gelatinase assays (previous section). Several studies have documented the contribution of 
gelatinase activity to retinal development, but none have examined the cerebellum. In the 
retina, MMP-2 and MMP-9 activity was observed in Müller cells, which form a 
“scaffold” structure like Bergmann glia, in growing neurites and growth cones, in the 
retinal pigment epithelium and the ECM surrounding photoreceptors (Limb et al., 2002; 
Padgett et al., 1997; Sheffield et al., 1994). There is strong evidence for the participation 
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of gelatinases in synapse formation (Taishi et al., 2001), differentiation (Chambaut-
Guerin et al., 2000), migration through glial scars (Muir et al., 2002) and tumor 
metastasis (Rooprai and McCormick, 1997). In the cerebellum, during the first three 
postnatal weeks, three of these processes (synapse formation, differentiation, and 
migration) are underway. Granule neurons are migrating from the EGL to the IGL, they 
are forming connections with Golgi cells and mossy fibers, and PCs, interneurons and 
glia are still differentiating (Altman, 1972a; Sotelo, 1990). In situ gelatinase activity is 
enhanced within the EGL, PCL, and the IGL, which suggests a role for MMP-2 and 
MMP-9 in some of these critical cellular events. 
 
Developmental changes in MMP-2 and MMP-9 immunoreactivity 
 
 
Inspection of the expression of MMP-2 and MMP-9, over time, by 
immunohistochemistry helped us understand the distribution of the enzymes relative to 
cells and cell layers (Figure 3.4-6). Staining with a polyclonal antibody against MMP-2 
coincided with the Purkinje cell layer, especially the soma and proximal dendritic trunks 
of PCs. This pattern was different from the immunoreactivity detected by calbindin 
D28k, which as expected labeled entire PCs including their dendrites. MMP-2 
immunoreactivity was also associated with radial processes that strongly resemble 
Bergmann glial fibers in size, location, and arrangement. Moreover, staining for MMP-2 
was present in the EGL. Staining for MMP-2 decreased below detection level at P15. 
Vaillant et al. (1999) observed MMP-2 immunoreactivity in the PCL, but not in the EGL 
or ML. This difference is probably due to several factors including the specificity of the 
 70
antibody we used (Santa Cruz), which recognizes the C-terminal domain common to both 
pro-MMP-2 and MMP-2. We performed several controls to ascertain the specificity of 
the antibody including negative controls, pre-absorption with a specific MMP-2 blocking 
peptide (data not shown), and by western blot analysis (Dr. Luo, unpublished data). The 
specificity of this antibody has been independently confirmed and successfully used by 
other authors (Wagner et al., 2003). Furthermore, CGN and glial cultures (Figure 3.2 E, 
F) showed strong gelatinase activity for MMP-2, which further supports our observations. 
Several developmental events occur during this period, including the migration of granule 
neurons and the extension of parallel fibers, the maturation of Bergmann glial fibers, and 
the ensheathment of Purkinje cell bodies by glial processes (Yamada and Watanabe, 
2002; Altman, 1972a; Altman, 1972b). The expression of MMP-2 in the EGL, Bergmann 
glial fibers, and the Purkinje cell layer suggests the involvement of MMP-2 in these 
developmental events.  
MMP-9 immunoreactivity was most intense in the EGL and in the Purkinje cells. 
Side by side comparision of MMP-9’s immunoreactivity to calbindin immunostaining, 
revealed a difference in the distribution. Whereas calbindin stained the entire Purkinje 
cell, MMP-9 was distributed in somata and dentrites but did not extend to smaller 
dendrites and spines. Furthermore, punctate staining for MMP-9 could be observed in the 
immediate pericellular space surrounding PCs. Similar punctate immunoreactivity for 
MMP-9 and other MMPs have been reported in trophoblasts of the human placenta and in 
malignant gliomas (Huppertz et al., 1998; Rooprai et al., 1998). MMP-9 has been shown 
to contribute to process extension of oligodendrocytes, to neurite extension, and dendritic 
remodeling in the hippocampus (Oh et al., 1999; Pittman and Williams, 1989; Uhm et al., 
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1998; Zhang et al., 1998). Diffuse and punctate staining around the dendrites (Figure 3.6) 
suggests a role in the degradation of ECM around extending neurites or synapse 
formation. The pattern of expression of MMP-9 also may suggest a role in the maturation 
of Purkinje cells and the branching and expansion of their dendritic trees. 
 
The effect of inhibiting gelatinases on cerebellar development in organotypic slice 
culture 
 
We next tried to demonstrate possible effects of diminishing MMP-2 and MMP-9 
on the histogenesis of the cerebellar cortex by exposing cerebellar slices to a selective 
MMP-2/MMP-9 inhibitor (Figure 3.8-10). Organotypic slice culture has been 
successfully used to study the development of the cerebellar cortex (Hager et al., 1995; 
Kunimoto and Suzuki, 1997). The cytoarchitecture of the cerebellar cortex is maintained 
(Tanaka et al., 1994; Bruckner and Grosche, 2001), even in organotypic slices prepared 
from P8 pups and cultured for 11 days in vitro (Takacs and Metzger, 2002). In our 
experiments, sections from cerebellar slices showed a developmental pattern that is 
comparable to what we observed in vivo (Figure 8A-C). Several experimental 
modifications seemed to improve the integrity of cultured slices like replacing the culture 
media every 48 hrs instead of 36 hrs, adding 10 µl of culture media on top of the slice, 
and placing slices side by side on the filter insert. The inhibitor we used (SB-3CT, VWR) 
has been shown to mimic the binding of TIMP-1 and TIMP-2 (Kleifeld et al., 2001). In 
situ zymography in sectioned cerebellar slices showed abberant activity in slices treated 
with the gelatinase inhibitor compared to controls (Figure 7E and F). This altered 
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gelatinase activity was most noticeable in the EGL and the IGL. We used two parameters 
to quantify the effects of MMP-2 and MMP-9 inhibitor on cerebellar cortical histogenesis 
in organotypic (Figure 3.10A and B). First, we measured the thickness of the EGL, which 
is an indirect indicator of the density of granule cells in the EGL. Secondly, we counted 
the number of small fusiform cells, presumed to be migrating granule neurons, in the ML. 
The first parameter pertains to the proliferative activity of progenitor cells and the rate of 
CGN exodus from the EGL. Combining this information with the number of migratory 
profiles allows us to assess the effect of inhibiting the function of gelatinases. A decrease 
in the thickness of the EGL could be due to lenghthening of the cell cycle or an increase 
in the rate of migration. The first condition leads to a decrease in the number of migrating 
profiles, while the second leads to a transient increase followed by a decrease due to 
reduction of the premigratory population in the deep EGL. An increase in the thickness of 
the EGL would indicate shortening of the cell cycle or a decrease in the rate of migration. 
Shortening the cell cycle will increase the packing density of cells and thickness of the 
EGL without affecting the number of migratory profiles in the ML, while a decrease in 
the number of migrating cells in the ML would be due to a decrease in the rate of 
migration.  
Inhibitor treatment resulted in a significant dose-dependent increase in the 
thickness of the EGL in slices cultured for 1 day (1DIV) and 10DIV compared to 
untreated controls. The number of fusiform cells in the ML, presumed to be migrating, 
decreased significantly in a dose dependent fashion in all treatment groups compared to 
controls. We speculate that the increase in the thickness of the EGL can be explained by 
an increase in the number of cells unable to start migration, whereas the decrease in 
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thickness at 10 DIV may be due to an increase in cell death, particularly in the 
postmitotic-premigratory population. A similar decrease in the thickness of the EGL was 
observed in cerebellar slices treated with methylmercury, which inhibited neuronal 
migration and caused an increase in pyknotic nuclei in the deep EGL as identified by 
BrdU pulse labeling and TUNEL (Kunimoto and Suzuki, 1997). Kunimoto and 
colleagues proposed that the retardation of migration may cause an increase in naturally 
occurring cell death that is thought to reduce the number of granule neurons (Wood et al., 
1993).  
The reduction in the number of migrating cells in the ML and the increase in 
thickness of the EGL was accompanied by a time- and dose-dependent decrease in 
gelatinase activity detected in cerebellar slices (Figure 9A-F). These data support the 
proposition that MMP-2 and MMP-9 may contribute to the migration of CGNs. The 
concentration of inhibitor we used (1.6 µM - 6.4µM), has been shown to have minimal 
effect on other MMPs (Brown et al., 2000) and on the viability of cells in vitro 
(Fingleton, 2003; Rosenblum et al., 2003). Other issues remain to be clarified about the 
effect of inhibitor treatment. It is not clear whether the decrease in migratory cell number 
is due to the decrease in the rate of migration, or is secondary to a decrease in the ability 
of postmitotic neurons to initiate migration. Gelatinases have been shown in other 
systems to promote cell motility and tumor metastasis (Gokaslan et al., 1998; Tokuraku 
et al., 1995). Gelatinase inhibitors has been shown to reduce the migration of Langerhans 
cells, skin dendritic cells (Ratzinger et al., 2002), and the migration of vascular smooth 
muscle cells (Pross et al., 2002). Although inhibitor treatment did not completely stop the 
migration of granule neurons, it decreased it significantly. Since the development of the 
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cerebellar cortex is dependent on intact interactions and normal development of its 
cellular constituents, then a role for gelatinases is strongly supported.  
Disturbing the development of granule neurons, by mutations or toxic 
compounds, is known to cause stunting of Purkinje dendrites and damage to Bergmann 
glia; disrupting the development of Purkinje neurons can have even gravier consequences 
(Ferguson, 1996; Bignami and Dahl, 1974; Adams et al., 2002; Altman and Anderson, 
1972; Llinas et al., 1973). The pattern of immunoreactivity of MMP-2 localizes around 
fusiform-shaped cells in the ML, presumably migrating granule neurons, and around 
granule neurons in the deep EGL, which supports a role in migration. MMP-2 
immunorectivity was also detetcted in Bergamnn glial fibers. Additionally, purified 
CGNs and glial cells from P4 cerebella had strong MMP-2 expression. Temporary 
“interstitial densities” have been shown to attach migrating granule neurons to BG fibers 
(Gregory et al., 1988). We speculate that Bergmann glia and/or granule neurons secrete 
MMP-2 to dissolve these densities and allow for further advancement of cells or 
processes. Gelatinases have been shown to facilitate the migration of gliomas (Uhm et al., 
1996), and of oligodendrocyte progenitors in vitro on an an astrocytic ECM by degrading 
temporary cell attachments (Uhm et al., 1998; Oh and Yong, 1996).  
We detected MMP-9 activity in purified CGNs, and immunoreactivity in the EGL 
and in Purkinje cell dendrites. This expression pattern indicates a role for MMP-9 in the 
migration of CGNs and in the growth of Purkinje cell dendrites. We speculate that the 
effect on migrating cells may be secondary to impeding the growth of Purkinje dendritic 
trees. This could be resolved by measuring the growth of Purkinje dendritic trees in 
treated slices compared to control slices. Damage to Purkinje cells by X-irradiation or 
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mutations is known to cause reduction in granule neuron numbers (Altman et al., 1969b; 
Bradley and Berry, 1978). Another possibility is that the inhibition of gelatinases reduced 
the ability of cells to degrade the ECM, which might have resulted in an increase in the 
packing density of cells in the EGL. Furthermore, the expression pattern in the EGL 
suggest a role for MMP-2 and MMP-9 in neurogenesis; a function suggested for MMP-9 
(Canete et al., 1995) but not for MMP-2. These possibilities, however, will require 
experimental evaluation. 
 
Concluding remarks and future directions 
 
Several studies reported the absence of MMP-2 transcript in normal adult tissue 
and elevated mRNA levels only in malignant tissue (Raithatha et al., 2000; Vince et al., 
1999; Lampert et al., 1998). The decrease in MMP-2 mRNA from developmental levels 
to adult levels has been reported to occur before birth (Casasco et al., 1995). Our data 
suggest that this decrease occurs postnatally in rats (Figure 3.1). Transcript levels of 
MMP-2 in the cerebellar and cerebral cortex declined progressively between P3 and P25. 
The possibility remains that MMP-2’s transcripts are expressed locally in certain cells, 
which could be verified by in situ hybridization. Furthermore, new technologies like laser 
capture microdissection (LCM, Acturus) or laser microdissection and pressure 
catapulting (LMPC, Carl Zeiss Inc.) allow the dissection of cells or small regions of 
tissue for RNA or DNA analysis. These techniques would allow the study of the 
expression of MMP-2 and MMP-9 by RT-PCR in cortical tissue, cortical layers, and in 
specific cell populations. 
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MMP-9 transcript showed an increase during the first two postnatal weeks in 
cerebral tissue, which consistently contained parts of the corpus callosum. The 
contribution of MMP-9 to process extension of oligodendrocytes and to myelination, 
have been previously proposed (Oh et al., 1999; Uhm et al., 1998). Myelination in the 
corpus callosum increases during the second postnatal week, but is delayed until after 
postnatal day 25 in the cerebellum (Wiggins, 1986; Raval-Fernandes and Rome, 1998; 
Hamano et al., 1998). Therefore, the increase in MMP-9 mRNA in cortical tissue may be 
partly due to the increase in myelination. If this speculation were true, we would expect 
to observe an increase in MMP-9 mRNA in the cerebellum after P25. A progressive 
decrease to adult MMP-9 mRNA levels would be expected as myelination subsides. 
Another possibility is that MMP-9 contributes to dendritic growth and plasticity. 
Evidence presented by Szklarczyk and colleagues (2002) suggests a role for MMP-9 in 
these functions in the adult nervous system but whether MMP-9 fulfills the same function 
during development remains to be explored.  
Genetic manipulations of the expression of MMPs provided ample knowledge 
about the mechanisms of activation and the consequences of abnormal expression. 
Knock-out studies of individual MMPs show no lethal mutants, which was attributed to 
the redundancy of MMPs and their broad spectrum of substrates (Shapiro, 1998).  
Overexpression of MMPs, such as MMP-2 and MMP-9, has been shown to contribute to 
the degradation of myelin and the BBB in MS, cancer metastasis, and other diseases 
(Beliveau et al., 1999; Wang et al., 2000; Yong et al., 1998). On the other hand, reduced 
expression and activation of MMPs has been linked with several brain pathologies 
especially Alzheimer’s disease (Asahina et al., 2001; Yong et al., 2001). Evidence from a 
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variety of experimental approaches suggests that pathologies arise from the disruption of 
more than one MMP, particularly MMPs like MMP-2 and MMP-9 that degrade common 
substrates. Inhibition of gelatinases has been shown to limit the extension of retinal 
growth cones by stopping the formation of filopodial processes (Sheffield et al., 1994). 
Outside the nervous system, the inhibition of gelatinases has been shown to reduce the 
migration of Langerhans cells, skin dendritic cells, and vascular smooth muscle cells 
(Pross et al., 2002). Furthermore, synthetic inhibitors of gelatinases have been 
successfully used to limit the metastasis of tumors in animal models, and are potential 
candidates for treating invasive tumors in humans (Brown et al., 2000; Marder and 
Greenwald, 2003; Rooprai and McCormick, 1997). 
The defects we observed in cerebellar slices after inhibitor exposure are probably 
due to the combined inhibition of MMP-2 and MMP-9. MMP-9 knock-out mice do not 
exhibit significant abnormalities in the development of the cerebellum (Shapiro, 1997). 
Gelatinases are similar to other MMPs in that they are zinc-dependent enzymes. 
Abnormalities in the development of the cerebellar cortex have been described in zinc-
deficient mice (Dvergsten et al., 1983). The damage to the cerebellar cortex, especially in 
the number of granule neurons and the thickness of EGL, was more severe in zinc-
deficient pups than in undernourished pair-fed pups. Toxic compounds are also known to 
damage the cerebellum during development (Antonio et al., 2002; Nielsen et al., 2003; 
Stoltenburg-Didinger et al., 1990). In rodents, in vitro and in vivo exposure of the 
cerebellum to methylmerucy, an animal model for Minamata disease, causes a severe 
decrease in the number of migrating granule neurons as seen in our study (Howard and 
Mottet, 1986; Kunimoto and Suzuki, 1997; Sager et al., 1982). Mercuric coumpounds 
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modulate the activity of MMPs, especially MMP-2 and MMP-9. Some organic mercurial 
coumpounds are known to induce gelatinase activity, whereas mercuric salts suppress the 
activity of gelatinases (de Souza et al., 2000; Sopata and Wize, 1979). The damage 
caused by a zinc-defiency and exposure to methylmercury involves a myriad of 
molecules, most of which are unknown. The damage, nevertheless, could possibly be 
due, at least in part, to disruption of the activity of MMPs.   
Sereral additional aspects of these results need to be addressed, especially the role 
of gelatinases in the extension of parallel fibers. MMP-9 contributes to process extension 
of oligodendrocytes and to neurite outgrowth in the retina (Letourneau et al., 1992; Uhm 
et al., 1998; Ferguson and Muir, 2000; Buttery and ffrench-Constant, 2001). We did not 
observe immunoreactivity for MMP-9 in association with parallel fibers. This might be 
due to our use of the parasagittal plane in all sections. As a result, our slices were all 
perpendicular to the direction of parallel fibers. The proposition that gelatinases 
contribute to the extension of parallel fibers might be addressed experimentally by 
performing immunohistochemitry for gelatinases on frontal sections. Furthermore, 
depositing small particles of DiI on the surface of the EGL, followed by 
immunohistochemistry for gelatinases in the frontal plane, would permit the validation of 
this proposition. We also observed MMP-2 and MMP-9 expression in the EGL and 
treatment with the MMP-2/MMP-9 inhibitor caused an increase in the thickness of the 
EGL. The increase in thickness could be due to an increase in proliferation, a decrease in 
migration, a decrease in cell death, or a combined effect. These possibilities are 
addressable by a variety of available techniques including the determination of the 
growth fraction (population of actively cycling cells) by BrdU labeling of proliferating 
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cells and determining the percentage of newborn BrdU-positive neurons that migrate 
after treatment with the gelatinase inhibitor. Furthermore, immunostaining of migrating 
ganule neurons with doublecortin will reduce the errors associated with the morphometric 
analysis. Determining the amount of cell death by TUNEL staining will help us assess the 
possible neurotoxic effect of blocking gelatinase activity on the cerebellar cortex. 
Furthermore, MMP-2 activity and expression coincided with EGL and fusiform-shaped 
cells, resembling migrating granule neurons, in the ML (Figure 3.5). Whether MMP-2 
contributes to the migration of progenitor neurons, between E14 and E17, from the 
rhombic lip to the EGL is yet to be determined.  
Matrix metalloproteinases, especially MMP-2 and MMP-9, have emerged as key 
contributors to several homeostatic mechanisms, including process extension and cell 
migration. These processes are essential to the formation of the cerebellar cortex and the 
normal development of the nervous system. More research is needed to clarify how these 
matrix-degrading enzymes are controlled and coordinated to serve such complex 
situations. The investigation of the contribution of gelatinases to earlier events in 
cerebellar corticogenesis are also important, especially the migration of progenitor cells 
from the rhombic lip to populate the EGL, and the migration of immature Purkinje 
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Figure 3.1 Real-time quantitative RT-PCR. A) The relative level of MMP-2 and 
MMP-9 mRNA in the cerebellar cortex (top graph) gradually decreased from P3 to P25. 
B) The expression pattern was different for MMP-9 but not for MMP-2 in the cerebral 





Figure 3.2 Gelatinase activity in the cerebellar cortex between P3 and P25. The 
cerebellum was dissected from rat pups at P3 until P25 and proteins were extracted from 
the tissue. Gelatin zymography showed digested bands of (A) pro-MMP-2 (72kDa) and 
MMP-2 (68 kDa); (B) pro-MMP-9 (92 kDa) and MMP-9 (82 kDa). We also performed a 
reverse zymographic assay to determine the presence of the gelatinase inhibitors TIMP-1 
(28kDa) and TIMP-2 (21kDa) in tissue extracts. Only TIMP-2 activity was present 
between P3 and P25 (C). As a loading control, we cut the top 2 cm of every gel following 
the electrophoresis and stain it with Coomassie blue stain for 5 min, which revealed 
bands of loaded proteins (D). We also performed gelatinase assay on cerebellar granule 
neurons (E) and mixed glial cells cultured from P4 cerebella (F). Gels were quantified 
with a densitometric analysis. (G) Shows densitometry for MMP-2, (H) shows 
densitometry for MMP-9, and (I) shows densitometry for TIMP-2. Experiments were 
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Figure 3.3 In situ Zymography in the developing cerebellum. Frozen tissue sections 
were incubated with Gelatin-FITC as a substrate (see methods). The digested gelatin 
fluoresces on tissue sections. (A) Gelatinase activity was present in the EGL and the 
Purkinje cell layer from P3 to P12. The activity increased in the IGL between P6 and 
P12. By P15 the activity decreased significantly in the cerebellum but was still detectable 
in the hippocampal formation in the same sections (scale: 800 µm). Inset shows 
gelatinase activity in the EGL, the Purkinje cell layer, and the IGL. Cells scattered in the 
WM also showed gelatinase activity, but the identity of these cells is not known (scale: 
250 µm). Panel (B) shows serial sections treated with 20 mM EDTA and 4% 
formaldehyde, which abolish gelatinase activity, and an adjacent untreated section 
processed for in situ zymography. Reaction product was detectable only in the untreated 














Figure 3.4  Immunohistochemical expression of MMP-2 and MMP-9. Panels showing 
representative sections from P6, P9, P12, P15, and P21 stained using anti-MMP-2, anti-
MMP-9, GFAP, and Calbindin D28k. All antibodies were detected with FITC-tagged 
secondary antibody (in green). In red is the nucleic-acid counterstain TOTO-3. (see 
results section for details). (EGL: external granule layer; ML: molecular layer; IGL: 

















































Figure 3.5 Detailed view of MMP-2 IHC. Sample images from P6 and P9 stained for 
MMP-2 (scale: 50 µm). Insets show from P6 and P9-MMP-2 at higher magnification in 
combined 2 channel images (FITC-TOTO3), and single channel images (Green = FITC). 
White arrows point to Bergmann glial fibers (see results section for details; scale: 20 µm; 











Figure 3.6 Detailed view of MMP-9 IHC. Sample images from P9 and P12 stained for 
MMP-9; scale: 50 µm). Insets show from P9 and P12-MMP-9 at higher magnification in 
combined 2 channel images (FITC-TOTO3), and single channel images (Green = FITC). 
White arrows point to Purkinje dendrites (see results section for details; scale: 20 µm; 










Figure 3.7 Control sections for MMP-9 IHC from P15 rat cerebellum. To determine 
the specificity of the antibodies used, serial sections were stained with the primary 
antibody pre-absorbed with an antibody-specific blocking peptide (see methods). Sample 
sections were incubated with the anti-MMP-9 alone (0:1) or with increasing dilution of 
the anti-MMP-9 blocking peptide (1:10, 1:20, and 1:50). As the concentration of the 
blocking peptide was reduced, the immunoreactivity of MMP-9 increased. Similar 
controls were done for MMP-2 (not shown; Mag bar: 100 µm). 
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Figure 3.8 Expression and activity of MMP-2 and MMP-9 in organotypic slice 
cultures. Sample sections from a control slice at 7 DIV stained with anti-MMP-9 (A), 
anti-MMP-2 (B), anti-Calbindin D28k (C), and anti-GFAP (D) then counterstained with 
the TOTO-3 (red; scale: 50 µm). MMP-2 and MMP-9 immunoreactivity in organotypic 
slices was similar to that observed in vivo. We performed in situ zymography on 
organotypic slices treated with a selective MMP2/MMP9 inhibitor. (E) Control section 
cultured for 7DIV without inhibitors. (F) Sample section from an adjacent slice to (E) and 
treated with 3.2 µM inhibitor for 7DIV shows reduced and aberrant gelatinase activity 











Figure 3.9 The effect of inhibitor treatment on the gelatinase activitity of MMP-2 
and MMP9 in vitro. Slices in culture were exposed to SB-3CT for 24hrs, and the 
conditioned media was collected and assayed for MMP activity. (A) Shows the gelatinase 
activity in control slices. (B) Shows the gelatinase activity in treated slices from 1DIV, 
4DIV, 7DIV and 10DIV. (C-G) show densitometric analysis for zymographic gels for 



































Figure 3.10 The effect of treatment with MMP-2/MMP-9 inhibitor on cerebellar 
corticogenesis. (A) Treatment with inhibitor caused an initial increase (1DIV and 4DIV), 
followed by a reduction in the thickness of the EGL. (B) The inhibitor reduced the 
number of migrating cells in the molecular layer in a dose-dependent manner. (n=3; p 
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Appendix 1: Detailed experimental protocols 
 
A1. Animal surgeries 
 
1. Prepare, clean and sterilize surgery tools.  
2. Sterilize work area with 5% Chlorox, then with 75% EtOH 
3. Anesthetize pups on ice (P3 and P6) or with 120 mg/kg injection of 
pentobarbital (P9 and older) 
4. Decapitate the pup and gently make a midline incision and deflect the scalp. 
Do not cut too deep, this will damage underlying neural tissue. Also do not 
apply pressure because it will cause the soft brain tissue to ooze out of the 
foramen magnum. 
5. Gently score the cranium with a scalpel and remove it with a pair of small 
forceps.   
6. Do the following step over a dish full of cold PBS. Turn the head upside 
down and sever the cranial nerves. The brain will drop into the PBS.  
N.B: For biochemical processing experiments, use ddH2O instead of PBS. 
Separate cerebellum from cerebrum and freeze tissue liquid nitrogen. Label 
tube (Cbl = cerebellum; Ctx = cerebral cortex; plus age) and store at -80ºC.  
7. Very carefully remove remaining meningies and place the brain in fixative.  
N.B: For in situ zymography experiments, do not use fixative. 
8. Cut a small cork and place it in a small embedding cube. Label the cube 
(IHC Px = immunohistochemistry + postnatal day; ISZ Px: in situ 
zymography + postnatal day). Cover the cork with tissue freezing compound 
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(O.C.T.), place brain on its side and cover entirely with O.C.T. Place the 
cube in powdered dry ice and cover with a thin layer of dry ice. 
9. Store cubes in -80ºC freezer until sectioning. 
10.  Important: use superfrost plus (Fisher 12-550-15) glass slides or coated 




1. Store cryostat sections, 12 µm thick, in plastic slide boxes wrapped with 
plastic wrap at -20ºC. 
2. Slides are inserted in plastic slide container (4 each; leave one slot empty for 
negative control) and placed on shaker for all subsequent steps. Need to 
prepare 12 ml of solutions to submerge the sections. Never let slides dry out 
between steps. 
3. Rinse slides in 25% ethanol in ddH2O for 15 min to remove all O.C.T. 
compound residues. 
4. Rinse slides in PBS-TX (0.1M PBS + 0.1% Triton-X 100) for 30 min. 
5. Incubate slides in primary Ab solution for 24 hrs at 4ºC on shaker. Dissolve 
goat-anti-MMP-9 and goat-anti-MMP-2 in PBS (1:1000). Dissolve mouse-
anti-Calbindin D28k (1:3000) and mouse-anti-GFAP (1:1000) in PBS/ PBS-
TX (1:1). 
6. Transfer antibody solutions individually into 50 ml conical tubes, label the 
tubes, and store them at 4ºC. Antibody solutions are good for a maximum of 
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1 month and can be reused 2 to 3 times. 
7. Rinse slides 3 times in PBS for a total of 30 min. During this time prepare 
secondary antibodies. For MMP-2 and MMP-9, dissolve anti-goat-FITC 
(1:300) and TOTO-3 (1:500) in PBS. For Calbindin D28k and GFAP, 
dissolve anti-mouse-FITC (1:300) and TOTO-3 (1:500) in PBS. Protect 
working solutions of secondary antibody from light by wrapping the tube 
with aluminum foil. Working solutions of secondary antibody can be reused 
2-3 times if stored at 4ºC. Remember to rinse the Control section in 25% 
ethanol for 15 min, followed by 30 min in PBS. Add control section to slide 
container and incubate all slides with secondary antibody 
8. Incubate slides in secondary antibody solution for 2 hrs at room temperature. 
Wrap the slide container with aluminum foil to prevent bleaching of 
seconday antibodies. 
9. Rinse slides 3 times in PBS for a total of 30 minutes. 
10. Gently blot excess fluid from around the sections (do not let them dry), add 
2-3 drops of mounting media (PBS-Glycerol 1:1 or Vectashield) and 
coverslip. Blot excess fluid from around the coverslips and seal the edges 
with a coat of clear and fast-drying nail polish. 
11. Store slides in a slide box at 4ºC. 
 
A3. In situ zymography 
 
1. Brains are dissected, embedded in O.C.T. compound and frozen without 
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fixation 
2.          Section brains and store sections in slide box at -20ºC 
3. Prepare reaction buffer: 0.05 M Tris-HCl, 0.15 M NaCl, 5 mM CaCl2, 0.2 
mM NaN3 (pH 7.6). Dissolve DQ™ gelatin-FITC (40 µg/ml; D-12054; 
Molecular Probes Inc., Eugene, OR) in reaction buffer in 50 ml conical tube. 
Place tube in warm water bath and shake for 30 sec or until the gelatin 
dissolves completely.  
4. Add staining solution to slide container and wrap it with aluminum foil. 
Place slide container on a shaker at 37ºC for 24 hours. 
5. Retrieve slides and blot excess fluid from around the sections. Don’t let the 
slides dry out. Add few drops of wet mounting media over the sections and 
coverslip the slides. Blot excess fluid from around the coverslips and seal 
the edges with fast-drying nail polish. 
6. Store slides at 4ºC. 
 
A4. Cerebellar cell culture 
 
Cerebellar granule neuron cell culture protocol: 
1. Dissect the cerebellum out and put the fresh tissue in a small tube of 1H 
solution 
2. When finished, finely chop all tissue with a razor blade on a glass slide 
3. Move chopped tissue to a 50ml conical tube and add solution A. lock tube 
well, shake several times, then incubate/shake at 37°C for 15 min. 
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4. Then, add solution C directly to the tube, shake and centrifuge for 15 sec at 
500 rpm 
5. Remove supernatant, add 5 ml solution B, swirl and mix well and let sit for 
5 min. 
6. Transfer supernatant to a 15ml tube; gently add solution D to about 12 ml 
7. Then spin down for 3 min at 2000 rpm 
8. Remove supernatant, keep pellet and add 5 ml of culture media and divide 
over dishes 
9. For glial culture, transfer supernatant to a flat culture bottle and add 10 ml 
DMEM and incubate. Change media every 3 days 
Stock solutions: 
1. trypsin: 25 mg/ml (T8003, sigma) 
2. trypsin inhibitor: 4 mg/ml soybean trypsin inhibitor (T9003, sigma) 
3. DNase: 200 U/ml DNAse I (D-4527, sigma) 
4. MgSO4, 7H2O: 3.82% (w/v) 
N.B: prepare all solutions in ddH2O 
1H buffer (50 ml): 50ml EBSS + 0.125 g Glucose + 0.15 g BSA + 0.5 ml MgSO4 stock 
A buffer (10 ml): 0.1 ml trypsin stock + 9.9 ml 1H buffer 
B buffer (10 ml): 8.6 ml 1H + 1 ml trypsin inhibitor Stock + 0.2 ml DNAse stock + 0.2 
ml MgSO4 stock 
C buffer (10 ml): 8.4 ml 1H + 1.6 ml B buffer 
D buffer (10 ml): 9.8 ml 1H + 400 mg BSA + 0.2 ml MgSO4 stock 
Culture media stock solutions: 
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1. KCl 2M: 7.2g + 50 ml ddH2O 
2. Glutamine 0.2M: 2.92 g + 100 ml ddH2O 
3. Glucose 1.33M (24%): 12 g + 50 ml 
4. Poly-D-Lysine 50 µg/ml in ddH2O (for coating slides and cover slips) 
 
For 100 ml medium: 1ml KCl + 1ml Glutamine stock + 2.5ml Glucose stock + 10ml FBS 
+ 1ml Pen/Strep (0.12ml gentamicin) + 85ml EMEM 
 
A5. Protein extraction 
 
(Monolayer cell culture) 
1. Remove culture medium with care. (Some cells easily detach from plate) 
2. Add 0.5 ml (the amount of buffer added may be increased if the cell culture 
is too dense) of RIPA buffer with freshly added inhibitors to cell culture 
plate. 
3. Scrap with a cell scraper and 1 ml pipetter up and down several times to 
shear membranes. Incubate on ice for 10 min. 
4. Spin down at 10,000g for 10 min at 4°C. 
5. Transfer the supernatant fluid, which is the total cell lysate, to clean 
eppendorf tubes and freeze at –20°C or run lowly assay to check protein 
concentration. 
RIPA buffer: 
1 x PBS 
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1% P-40 
0.5% sodium deoxycholate 
0.1% SDS 
RIPA buffer with inhibitors (make fresh): 
10 mg/ml PMSF at 10ml/ml RIPA 
Aprotinin (Sigma #A6279 as liquid) at 30 µl/ml RIPA 
100mM sodium orthovanadate at 10ml/ml RIPA 
Lowly assay (for microplate assay) 40: 
1. Make A’: Add 20 ml of A to 1 ml of S. 
2. Prepare 5 dilution of protein standard (BSA) from 0.0875, 0.175, 0.35, 0.7, 
1.4 mg/ml. Standard curve should be prepared each time the assay is 
performed. 
N.B: prepare all samples and standards in triplicates 
3. Add 5 µl of standard and samples into a clean microtiter plate. 
4. Add 25 µl of A’ into each well. 
5. Add 200 µl of B into each well; gently agitate the plate to mix the reagents. 
(Avoid air bubbles) 
6. Incubate at room temperature for 15 min and read absorbance at 750nm 
(program 33) 
7. Calculate average protein concentration in µg/µl. 
8. Maximum volume to load in a gel with 0.75 mm wells is 25 µl and 60 µl in 
a gel with 1.5 mm wells.  
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9. Prepare aliquots with 16 µl (protein + RIPA buffer) + 5 µl sample buffer 
minutes before loading in the gel 
 
Tissue Age Ave. Conc. (µg/µl) Protein (µg) Protein (µl) RIPA buffer (µl) 
  P3 34.13  853.25  5.9 10.1 
Cerebellar P6 30.82  770.5     6.5 9.5 
 Cortex P9 45.57  1139.25  4.4 11.6 
  P12 49.46  1236.5  4 12 
  P15 36.46  911.5     5.5 10.5 
  P18 40.37  1009.25  4.9 11.1 
  P21 44.6    1115      4.5 11.5 
  P25 34.13  853.25  5.9 10.1 
  P30 35.62  915.5     5.5 10.5 
  P3 25.89  647.25  7.7 8.3 
 Cerebral P6 29.38  734.5     6.8 9.2 
 Cortex P9 29.27  731.75  6.8 9.2 
  P12 33.64  841       6 10 
  P15 37.47  936.75  5.3 10.7 
  P18 36.74  918.5    5.4 10.6 
  P21 21.7    542.5    9.2 6.8 
  P25 19.38  484.5    10.3 5.7 
  P30 37.78  944.5    5.3 10.7 
 
Table 1. Protein concentration for gelatinase assay. Example from Tuesday, Nov. 27 2001 
 
A6. Gelatinase assay 
 
Note: Zymographic analysis = Gelatinase assay 
         Gelatinolytic activity = Gelatin degrading activity 
10% Separating Gel: 15ml 
Dissolve 15mg gelatin in 7.5ml ddH2O by heating in stir plate. 
Add 3.75 ml 4X separating buffer after cooling to RT 
Add 3.75 ml 40% 37.5:1 acrylamine/Bisacrylamine 
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Add 100 µl 10% APS, mix well 
Add 20 µl TEMED 
Stacking Gel: 
37.5:1 Acrylamine/Bisacrylamine 1 ml 
4X stacking buffer   2.5 ml 
ddH2O     6.5 ml 
10% APS    50 µl 
TEMED    10 µl 
Samples preparation and electrophoresis: 
1. Prepare samples in 4X sample buffer (non-reducing, 40mM Tris-HCL pH 8, 
80% Glycerin, 8% SDS, 0.4% Bromophenol blue). Do not heat samples 
before loading. 
2. Fill the container with Protein Running Buffer. Load samples in the 
electrophoretic gel. Max load: 25 µl in 0.75 mm plate.  
3. Attach the gel container to the power supply and adjust the current intensity 
to 0.32 mA. Let the gel run for 2 to 3 hours (until the blue dye starts to run 
down). 
4.          Wash gel in 2.5% Triton-100 for 30 min 
5. Switch to 50mM Tris-HCL pH 7.4, 0.1M NaCl, 2.5% Triton-100 for 
additional 60 min 
6. Incubate in reaction buffer (50mM Tris-HCL pH 7.4, 10mM CaCl2) 
overnight at 37°C. 
7. Stain the gel with 0.5% coomassie blueR in 45%MeOH, 10% acetic acid for 
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30 min at room temperature on shaker. 
8. De-stain the gel in destaining solution (10% MeOH, 10% acetic acid) 
9. Take picture of gel on the Eaglesight® workstation. 
 
A7. Reverse zymography assay 
Gel preparation: 
Separating Gel (12%): 
1. Dissolve 15 mg gelatin in 6.75 ml ddH2O. Put tube in hot water bath until 
gelatin dissolves. 
2. 4.5 ml of 40% 37.5:1 Acrylamine/Bisacrylamine 
3. 3.75 ml 4X Separating Buffer 
4. 15 µl of 0.2 µg/ml pro-MMP2 (Calbiochem 444213) 
5. 75 µl 10% APS 
6. 15 µl TEMED 
Overlay gel with ddH2O 
 
Stacking Gel: 
1. 1 ml of 40% 37.5:1 Acrylamine/Bisacrylamine 
2. 2.5 ml Stacking Buffer 
3. 6.5 ml ddH2O 
4. 50 µl 10% APS 
5. 10 µl TEMED 
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Let the gel run for 2 hours 
N.B: sample preparation, incubation time and staining are the same as in Gelatinase 
Assay 
A8. Organotypic slice culture 
Solutions: 
1. Culture media: 46% Eagle’s basal medium + 25% Earl’s balanced salt 
solution + 25% horse serum + 1% penicillin-streptomycin-glutamine 
(penicillin 105 units/ml; streptomycin 10 mg/ml; 29.2 mg.ml-1) + 6.5 mg/ml 
glucose. Adjust pH to 7.2. Store culture media in an autoclaved bottle at 4ºC 
until use. 
2. ACSF: 126.0 mM NaCl + 3.0 mM KCl + 1.3 mM MgSO4 + 2.5 mM CaCl2 
+ 1.2 mM NaH2PO4 + 26 mM NaHCO3 + 20 mM dextrose. Keep ACSF at 
4ºC. Bubble ACSF in O2:CO2 gas mixture (95%:5%) for 15 min before use. 
3. Autoclave all paper towels, surgery tools and glassware 
4. Perform all steps under sterile conditions in a laminar flow hood.  Clean 
space with a mixture of 25% ethanol and 2% chlorox before use. 
 Procedure: 
5. Prepare six plates. Put 1 ml of culture medium in the well. Place Millicell 
membrane-inserts (Cat# PICMORG50, Millipore, Bedford, MA) over the 
culture media and try to avoid air bubbles. 
6. Anesthesize rat pups (P5) by cooling on ice. Rub head with 75% ethanol. 
7. Decapitate pups and quickly dissect the hind brain including, the 
cerebellum, out. 
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7.  Place the cerebellum in a Petri dish filled with ice cold ACSF. 
8. Under magnifying glass, make a cut behind the inferior colliculus and gently 
separate the cerebellum from the pons. Make a sagittal cut 2 mm lateral to 
the vermis. 
9.  Glue flat surface down on the stage of vibraslicer (WPI, Sarasota, FL), and 
immerse in ACSF. 
10. Sections the cerebellum at 500 µm thickness. Collect slices from the vermal 
region and few millimeters around it. 
11. Gently transfer slices to the millicel membrane. Arrange only 2 slices over 
every membrane and place 20 µl of culture media on top of the slices. Use 
only 4 wells from the six-well culture plate. One well is for control slices, 
while the other three are for treatment groups. 
12. Incubate culture plates at 35ºC with 5% CO2 atmosphere. 
13. Replace culture media every 2 days. Warm the culture media to 35ºC before 
adding to the culture plate. 
A9. MMP inhibitor treatment 
 
1. Dilute the gelatinase inhibitor (SB-3CT) in culture media to a final 
concentration of 1.6 µM, 3.2 µM, and 6.4 µM. Prepare inhibitor solution 
from aliquots 30 min before treatment and allow the solution to warm up to 
37ºC.  
2. Start treat slices with the inhibitor 6 hrs after the beginning of the slice 
culture.  
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3. For 1DIV, harvest the slices 24 hrs after the initial treatment. Place metal 
block in -80ºC freezer the night before. Place glass slides on the metal block 
and place few drops of O.C.T. compound on them. Sandwich the O.C.T. 
compound between two cold glass slides and let it freeze (Figure1, a-c). The 
O.C.T. compound should freeze flat like a coin. Detach the glass slides from 
the frozen O.C.T. coin by rubbing the surface lightly with your finger. Place 
the frozen O.C.T. coin flat on the metal block. Cover a tissue slice with 
O.C.T. compound and gently place it on the frozen O.C.T. coin using a paint 
brush (Figure 1d). Cover the slice with powdered dry ice and let it freeze 
(Figure 1e).  
 
Figure 1. Freezing slices for IHC and ISZ. Refer to text for details. 
 
4. Pipette out the culture media from the culture plate and place in pre-labeled 







5. For the remaining treatment groups, replace the culture media with the 
inhibitor every two days or 24 hrs before collecting the slices, and repeat the 
procedure in (3). 
A10. Morphometric analysis 
1. Sampling frames were chosen by systematic random sampling.  All frames 
are of equal size using a 20x objective. Fame size= 325.7 x 325.7 
2. Using the LSM510 software, choose “Overlay” from the menue and pick the 
following: line thickness, color (white), ruler, and curved line. 
 
Figure 2. Morphometric analysis in cerebellar sections. Sample frame from 4DIV 1.6 
µM section. We measured the thickness of the EGL and the number of 








3. Draw 3 lines: line 1 borders the EGL-pia, line 2 borders the EGL-ML, and 
line 3 through the nuclei of Purkinje cell (Figure 2). 
4. Draw 2 circles between line 1 and line 2. The circles have to touch the lines 
at 2 points, one point on each line. Record the area (A) of each circle 
5. To determine the distance (D) between the lines, apply the following 
formula in Excel: D = 2*SQRT(A/Pi ()) 
6. Count the cells between line 2 and 3. Choose only clearly visible cells with 
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2001- 2003 Graduate student representative, Department of Neurobiology and 
Anatomy 
2001-    Student Leadership Committee, WVU School of Medicine  
 
Teaching Experience  
Spring 2003  Medical Neurobiology (CCMD 775) 
Spring 2002  Medical Neurobiology (CCMD 775) 
Spring 2002 Continuing Education for Psychiatry Residents at Chestnut Ridge 
Hospital (Internal structures of the CNS) 
Spring 2001  Medical Neurobiology (CCMD 775) 
Spring 2000  Medical Microanatomy (ANAT 723)  
 
Seminar Presentations 
2003 The matrix metalloproteinases 2 and 9 are expressed in the 
developing cerebellar cortex and are disrupted by ethanol 
exposure, Van Liere Research Symposium. 
2003 Contribution of MMP-2 and MMP-9 to the postnatal development 
of the rat cerebellar cortex, Dept. of Neurobiology at Yale  
University School of Medcicine. 
2002 Contribution of MMP-2 and MMP-9 to the development of the 
cerebellar cortex and the effect of ethanol exposure, Dept. of 
Neurobiology and Anatomy. 
2001 Structural Plasticity of Microglia in the hypothalamic SON, Dept. 
of Neurobiology and Anatomy. 
2000 Microglial plasticity in the Supraoptic Nucleus, Van Liere 
Research Symposium. 
1999 Neurobiology of Neurotrophins (A Review), Dept. of 




2001-2003 Contribution of MMPs to the development of the cerebellar 
granule neurons and the effect of ethanol exposure. Advisor: J. 
Luo, Ph.D. 
2001   Developmental neurobiology of oligodendrocyte progenitors. 
   Research Rotation; Laboratory of R. C. Wiggins, Ph.D. 
2000   Plasticity of Microglia in the hypothalamic SON 
   Research Rotation; Laboratory of A. K. Salm, Ph.D. 
1999 Molecular aspects of ROS-induced oligodendrocyte injury. 
Research Rotation; Laboratory of G. W. Konat, Ph.D./L.M. 
1999   Structural organization of auditory brain stem (SOC) circuitry. 
   Research Rotation; Laboratory of A. S. Berrebi, Ph.D. 
1998   Glial plasticity in the hypothalamic SON 
   Summer Research Fellowship; Laboratory of A. K. Salm, Ph.D. 
1998 Feeding competition and dominance in the shrimp Palaemonetes 
vulagris. Co-investigator (33 % effort). Undergraduate Research 
Honors Project; Department of Biology. 
 
Publications 
Ayoub A. E. and Luo J. (2003) On the Contribution of MMP-2 and MMP-9 to the 
Postnatal Cerebellar Corticogenesis (in preparation) 
 
Ayoub A. E. and Salm A. K. (2003) Increased morphological diversity of microglia in the 
activated hypothalamic supraoptic nucleus. J Neurosci 23(21):7759-66 
  
Salm A.K., Ayoub A. E., Lally B. E. (2003) Structural plasticity of nonneuronal cells in 
the hypothalamo-neurohypophyseal system: in the right place at the right time. Advances 
in Molecular and Cell Biology, Vol. 31:181-199 (in press). 
 
Ayoub A.E., Lin H., Li Z., Ma C., Kaplan R., Cai T., Wiggins R.C., Luo J. 
Developmental expression of matrix-metalloproteinases in the rat cerebellar cortex: 
impact of ethanol exposure. Soc. Neurosci. Abstr. 28: 727.10 2002 
 
Ayoub A.E. and Salm A. K. Morphological plasticity of microglia in the activated 
supraoptic nucleus. Soc. Neurosci. Abstr. 26: 726.7 2000 
 
 
 
